An autosomal recessive inborn error of immunity caused by biallelic loss-of-function variants in CORO1A, which encodes coronin-1A, an actin regulator expressed mainly in haematopoietic cells. The index patient had T-B+NK+ severe combined immunodeficiency with a thymus that was paradoxically detectable, and later families widened the picture to a combined immunodeficiency of childhood or young adulthood dominated by severe viral disease: EBV-driven B-cell lymphoproliferation and lymphoma, disseminated or post-vaccination varicella, epidermodysplasia verruciformis-like beta-HPV disease, molluscum contagiosum and herpetic ulcers. The mechanism is a failure of cytoskeletal regulation rather than of antigen receptor rearrangement or cytokine signalling. Coronin-1A restrains Arp2/3-dependent filamentous actin assembly; without it, lymphocytes accumulate F-actin, mature T cells migrate poorly and are not released from the thymus, and peripheral T cells die more readily. The result is a profound deficiency of naive T cells with a restricted repertoire and near-absent innate-like T cells (iNKT and MAIT). NK-cell killing also depends on coronin-1A-mediated F-actin deconstruction at the lytic synapse, and loss of T, NK and innate-like T-cell control of EBV-infected B cells is the route to the lymphoproliferative disease that marks this disorder. Two caveats shape the entry. First, the clinical series is very small, so the frequencies recorded here come from a nine-patient review table and should be read as such. Second, the mouse and human data disagree on one point: Coro1a-null mouse T cells have a severe calcium-mobilization defect that was proposed to explain their poor survival, whereas T cells from patients carrying a C-terminal frameshift allele have poor survival with near-normal calcium flux. That disagreement is recorded as a discussion rather than resolved in the pathograph. One patient's attention deficit hyperactivity disorder is attributed by its authors to the 600-kb 16p11.2 deletion that removed her second CORO1A allele, not to coronin-1A loss itself; the entry models it through a separate contiguous-gene node. No GeneReviews chapter exists for this disorder (checked against the Bookshelf index and PubMed). No pathophysiology node declares conforms_to; kb/modules/ has no module for cortical actin regulation in lymphocytes.
Ask a research question about Severe Combined Immunodeficiency Due To CORO1A Deficiency. OpenScientist will conduct autonomous deep research using the Disorder Mechanisms Knowledge Base and PubMed literature (typically 10-30 minutes).
Do not include personal health information in your question. Questions and results are cached in your browser's local storage.
name: Severe Combined Immunodeficiency Due To CORO1A Deficiency
creation_date: "2026-09-28T20:00:00Z"
category: Mendelian
synonyms:
- coronin-1A deficiency
- SCID due to CORO1A deficiency
- SCID due to coronin-1A deficiency
- severe combined immunodeficiency due to coronin-1A deficiency
- immunodeficiency 8
- immunodeficiency type 8
- immunodeficiency 8 with lymphoproliferation
- IMD8
disease_term:
preferred_term: severe combined immunodeficiency due to CORO1A deficiency
term:
id: MONDO:0014168
label: severe combined immunodeficiency due to CORO1A deficiency
parents:
- Severe combined immunodeficiency
- Combined immunodeficiency
description: >-
An autosomal recessive inborn error of immunity caused by biallelic
loss-of-function variants in CORO1A, which encodes coronin-1A, an actin
regulator expressed mainly in haematopoietic cells. The index patient had
T-B+NK+ severe combined immunodeficiency with a thymus that was paradoxically
detectable, and later families widened the picture to a combined
immunodeficiency of childhood or young adulthood dominated by severe viral
disease: EBV-driven B-cell lymphoproliferation and lymphoma, disseminated or
post-vaccination varicella, epidermodysplasia verruciformis-like beta-HPV
disease, molluscum contagiosum and herpetic ulcers.
The mechanism is a failure of cytoskeletal regulation rather than of antigen
receptor rearrangement or cytokine signalling. Coronin-1A restrains
Arp2/3-dependent filamentous actin assembly; without it, lymphocytes
accumulate F-actin, mature T cells migrate poorly and are not released from
the thymus, and peripheral T cells die more readily. The result is a profound
deficiency of naive T cells with a restricted repertoire and near-absent
innate-like T cells (iNKT and MAIT). NK-cell killing also depends on
coronin-1A-mediated F-actin deconstruction at the lytic synapse, and loss of
T, NK and innate-like T-cell control of EBV-infected B cells is the route to
the lymphoproliferative disease that marks this disorder.
Two caveats shape the entry. First, the clinical series is very small, so
the frequencies recorded here come from a nine-patient review table and
should be read as such. Second, the mouse and human data disagree on one
point: Coro1a-null mouse T cells have a severe calcium-mobilization defect
that was proposed to explain their poor survival, whereas T cells from
patients carrying a C-terminal frameshift allele have poor survival with
near-normal calcium flux. That disagreement is recorded as a discussion
rather than resolved in the pathograph.
One patient's attention deficit hyperactivity disorder is attributed by its
authors to the 600-kb 16p11.2 deletion that removed her second CORO1A allele,
not to coronin-1A loss itself; the entry models it through a separate
contiguous-gene node. No GeneReviews chapter exists for this disorder
(checked against the Bookshelf index and PubMed). No pathophysiology node
declares conforms_to; kb/modules/ has no module for cortical actin
regulation in lymphocytes.
classifications:
harrisons_chapter:
- classification_value: IMMUNE_RHEUMATOLOGIC
evidence:
- reference: PMID:18836449
reference_title: "The actin regulator coronin 1A is mutant in a thymic egress-deficient mouse strain and in a patient with severe combined immunodeficiency."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "a T cell-deficient, B cell-sufficient and natural killer cell-sufficient patient with severe combined immunodeficiency, whom we found had mutations in both CORO1A alleles"
explanation: >-
The disorder is a severe combined immunodeficiency, an immune-system
disease belonging to Harrison's immunology part.
- classification_value: GENETICS_ENVIRONMENT_DISEASE
evidence:
- reference: PMID:25073507
reference_title: "Compound heterozygous CORO1A mutations in siblings with a mucocutaneous-immunodeficiency syndrome of epidermodysplasia verruciformis-HPV, molluscum contagiosum and granulomatous tuberculoid leprosy."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "Coronin-1A deficiency is a recently recognized autosomal recessive primary immunodeficiency caused by mutations in CORO1A"
explanation: >-
A monogenic, autosomal recessive disorder, supporting placement in
Harrison's genetics-and-disease part as well.
iuis_category:
classification_value: combined immunodeficiency
notes: >-
The founding patient had the T-B+NK+ SCID immunophenotype, which the IUIS
scheme files in Table 1 (immunodeficiencies affecting cellular and humoral
immunity) rather than among the syndromic combined immunodeficiencies.
evidence:
- reference: PMID:18836449
reference_title: "The actin regulator coronin 1A is mutant in a thymic egress-deficient mouse strain and in a patient with severe combined immunodeficiency."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "a T cell-deficient, B cell-sufficient and natural killer cell-sufficient patient with severe combined immunodeficiency, whom we found had mutations in both CORO1A alleles"
explanation: >-
Establishes the T-B+NK+ severe combined immunodeficiency phenotype that
places the disorder in the IUIS combined-immunodeficiency table.
inheritance:
- name: Autosomal recessive
inheritance_term:
preferred_term: Autosomal recessive inheritance
term:
id: HP:0000007
label: Autosomal recessive inheritance
description: >-
Affected individuals carry two deleterious CORO1A alleles, homozygous in
consanguineous families or compound heterozygous, including one case where
the second allele was removed by a de novo 16p11.2 deletion.
evidence:
- reference: PMID:25073507
reference_title: "Compound heterozygous CORO1A mutations in siblings with a mucocutaneous-immunodeficiency syndrome of epidermodysplasia verruciformis-HPV, molluscum contagiosum and granulomatous tuberculoid leprosy."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "Coronin-1A deficiency is a recently recognized autosomal recessive primary immunodeficiency caused by mutations in CORO1A"
explanation: States the autosomal recessive mode of inheritance directly.
- reference: PMID:23522482
reference_title: "Whole-exome sequencing identifies Coronin-1A deficiency in 3 siblings with immunodeficiency and EBV-associated B-cell lymphoproliferation."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "We identified a homozygous inherited missense mutation in the gene encoding Coronin-1A (CORO1A) in the 3 siblings."
explanation: >-
Homozygosity in three affected siblings of a consanguineous family is the
segregation pattern expected for recessive inheritance.
prevalence:
- population: Worldwide, reported cases
measure_type: CASES_IN_LITERATURE
prevalence_class: ULTRA_RARE
notes: >-
No population-based estimate exists. A 2024 report counts fewer than 20
patients with germline biallelic CORO1A variants; a 2018 review table
summarizes nine.
evidence:
- reference: PMID:37915722
reference_title: "Novel hemizygous CORO1A variant leads to combined immunodeficiency with defective platelet calcium signaling and cell mobility."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "To date, fewer than 20 patients have been identified as having germline biallelic mutations in the coronin-1A gene (CORO1A)"
explanation: Gives the size of the reported patient population.
- reference: PMID:29942301
reference_title: "Inherited Immunodeficiencies With High Predisposition to Epstein-Barr Virus-Driven Lymphoproliferative Diseases."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
quote_role: REVIEW_SYNTHESIS
snippet: "Deficiency in the actin regulator CORO1A (Coronin-1A) has been identified in nine patients"
explanation: >-
A review's count of the cases it tabulates; the source of the
nine-patient denominators used for phenotype frequencies below.
pathophysiology:
- name: Biallelic CORO1A Loss-of-Function Variants
biological_scale: MOLECULAR
description: >-
Germline biallelic CORO1A variants: frameshift truncations, a homozygous
beta-propeller missense change (p.V134M) that almost abolishes protein
expression, a paternal 2-bp deletion paired with a de novo 16p11.2
deletion, and a homozygous C-terminal frameshift (p.S401fs) that is
expressed but cannot oligomerize or associate with the cytoskeleton. Every
reported allele removes coronin-1A protein or the domains it needs to act
on actin.
genetic_context:
variant_origin: GERMLINE
functional_impact_category: LOSS_OF_FUNCTION
genes:
- preferred_term: CORO1A
term:
id: hgnc:2252
label: CORO1A
molecular_functions:
- preferred_term: actin filament binding
modifier: DECREASED
term:
id: GO:0051015
label: actin filament binding
downstream:
- target: Loss of Coronin-1A Inhibition of Arp2/3
causal_link_type: DIRECT
description: >-
Absent or truncated coronin-1A removes the protein's inhibitory action on
the Arp2/3 actin-nucleation complex.
evidence:
- reference: PMID:26476480
reference_title: "Recurrent viral infections associated with a homozygous CORO1A mutation that disrupts oligomerization and cytoskeletal association."
supports: SUPPORT
evidence_source: IN_VITRO
quote_role: BACKGROUND
snippet: "the CC domain is necessary for the inhibitory role of CORO1A on Arp2/3-dependent F-actin branching and accumulation"
explanation: >-
Background statement of an in-vitro biochemical finding: the C-terminal domain lost in
the S401fs allele is the one required for Arp2/3 inhibition, linking the
lesion to the loss of that activity.
evidence:
- reference: PMID:26476480
reference_title: Recurrent viral infections associated with a homozygous CORO1A mutation that disrupts oligomerization and cytoskeletal association.
supports: SUPPORT
evidence_source: IN_VITRO
quote_role: BACKGROUND
snippet: "CORO1A associates with the actin cytoskeleton, binds to F-actin, and localizes at sites of actin assembly."
explanation: >-
Grounds the molecular-function binding: coronin-1A is an F-actin-binding
protein. The same paper shows the S401fs allele loses cytoskeletal
association, and the other alleles remove the protein, hence DECREASED.
- reference: PMID:18836449
reference_title: "The actin regulator coronin 1A is mutant in a thymic egress-deficient mouse strain and in a patient with severe combined immunodeficiency."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "a T cell-deficient, B cell-sufficient and natural killer cell-sufficient patient with severe combined immunodeficiency, whom we found had mutations in both CORO1A alleles"
explanation: The founding patient carried mutations on both CORO1A alleles.
- reference: PMID:19097825
reference_title: "Severe combined immunodeficiency (SCID) and attention deficit hyperactivity disorder (ADHD) associated with a Coronin-1A mutation and a chromosome 16p11.2 deletion."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "Molecular analysis revealed a 2 bp deletion in the paternal CORO1A coding sequence paired with a 600 kb de novo deletion encompassing CORO1A on the maternal allele."
explanation: >-
The genotype of the same patient: a frameshift allele in trans with a
deletion of the whole gene.
- reference: PMID:23522482
reference_title: "Whole-exome sequencing identifies Coronin-1A deficiency in 3 siblings with immunodeficiency and EBV-associated B-cell lymphoproliferation."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "This mutation, p. V134M, results in the substitution of an evolutionarily conserved amino acid within the β-propeller domain, which abrogates almost completely the protein expression in the patients' cells."
explanation: >-
A missense allele that acts as loss of function by almost abolishing
protein expression in patient cells.
- reference: PMID:25073507
reference_title: "Compound heterozygous CORO1A mutations in siblings with a mucocutaneous-immunodeficiency syndrome of epidermodysplasia verruciformis-HPV, molluscum contagiosum and granulomatous tuberculoid leprosy."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "We found the compound heterozygous CORO1A variants: c.248_249delCT (p.P83RfsX10) and a novel mutation c.1077delC (p.Q360RfsX44)"
explanation: Two frameshift alleles in trans in an affected sibship.
- reference: PMID:26476480
reference_title: "Recurrent viral infections associated with a homozygous CORO1A mutation that disrupts oligomerization and cytoskeletal association."
supports: SUPPORT
evidence_source: IN_VITRO
snippet: "The CORO1A(S401fs) mutant was expressed in the patients' lymphocytes at a level comparable with that of wild-type CORO1A in normal lymphocytes but did not oligomerize and had impaired cytoskeletal association."
explanation: >-
An allele that preserves protein amount but loses oligomerization and
cytoskeletal association, so it is functionally deficient rather than
absent.
- name: Loss of Coronin-1A Inhibition of Arp2/3
biological_scale: MOLECULAR
description: >-
Coronin-1A binds F-actin and the Arp2/3 complex and restrains
Arp2/3-mediated actin branching; its C-terminal coiled-coil domain is
required for that inhibition. Loss of the protein or of that domain removes
the brake on steady-state F-actin formation.
biological_processes:
- preferred_term: negative regulation of Arp2/3 complex-mediated actin nucleation
modifier: DECREASED
term:
id: GO:0034316
label: negative regulation of Arp2/3 complex-mediated actin nucleation
downstream:
- target: Filamentous Actin Accumulation in Lymphocytes
causal_link_type: DIRECT
evidence:
- reference: PMID:16902139
reference_title: "Requirement for coronin 1 in T lymphocyte trafficking and cellular homeostasis."
supports: SUPPORT
evidence_source: MODEL_ORGANISM
snippet: "We generated coronin 1-/- mice and found that coronin 1 exerted an inhibitory effect on cellular steady-state F-actin formation via an Arp2/3-dependent mechanism."
explanation: >-
In knockout mice, loss of coronin 1 releases an Arp2/3-dependent brake
on F-actin formation.
evidence:
- reference: PMID:16902139
reference_title: "Requirement for coronin 1 in T lymphocyte trafficking and cellular homeostasis."
supports: SUPPORT
evidence_source: MODEL_ORGANISM
snippet: "coronin 1 exerted an inhibitory effect on cellular steady-state F-actin formation via an Arp2/3-dependent mechanism"
explanation: Establishes the Arp2/3-dependent inhibitory activity that is lost.
- name: Filamentous Actin Accumulation in Lymphocytes
biological_scale: CELLULAR
description: >-
T cells lacking functional coronin-1A carry excess F-actin, and at the NK
lytic synapse the F-actin density that coronin-1A normally deconstructs is
not cleared. Accumulated, poorly dynamic cortical actin is the shared
cellular lesion behind the migration, survival and cytotoxicity defects
that follow.
biological_processes:
- preferred_term: actin filament depolymerization
modifier: DECREASED
term:
id: GO:0030042
label: actin filament depolymerization
cell_types:
- preferred_term: T cell
term:
id: CL:0000084
label: T cell
- preferred_term: natural killer cell
term:
id: CL:0000623
label: natural killer cell
downstream:
- target: Impaired T-Cell Migration and Thymic Egress
causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
evidence:
- reference: PMID:16902139
reference_title: "Requirement for coronin 1 in T lymphocyte trafficking and cellular homeostasis."
supports: SUPPORT
evidence_source: MODEL_ORGANISM
snippet: "Whereas coronin 1 was required for chemokine-mediated migration, it was dispensable for T cell antigen receptor functions in T cells."
explanation: >-
The same knockout T cells that accumulate F-actin fail
chemokine-directed migration.
- target: Reduced Peripheral T-Cell Survival
causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
evidence:
- reference: PMID:26476480
reference_title: "Recurrent viral infections associated with a homozygous CORO1A mutation that disrupts oligomerization and cytoskeletal association."
supports: SUPPORT
directness: INDIRECT
evidence_source: IN_VITRO
snippet: "In our patients, we propose that the failure of the CORO1AS401fs to oligomerize and to associate with the cytoskeleton leads to abnormal accumulation of F-actin and impaired T cell survival."
explanation: >-
The authors propose F-actin accumulation as the cause of the survival
defect in their patients; this is stated as a proposal, not
demonstrated, hence INDIRECT.
- reference: PMID:16902139
reference_title: "Requirement for coronin 1 in T lymphocyte trafficking and cellular homeostasis."
supports: SUPPORT
directness: INDIRECT
evidence_source: MODEL_ORGANISM
snippet: "Moreover, actin dynamics, through a mitochondrial pathway, was linked to lymphocyte homeostasis."
explanation: >-
Mouse evidence linking the actin defect to lymphocyte homeostasis
through a mitochondrial (apoptotic) pathway.
- target: Impaired NK-Cell Lytic Synapse Function
causal_link_type: DIRECT
evidence:
- reference: PMID:24760828
reference_title: "Lytic immune synapse function requires filamentous actin deconstruction by Coronin 1A."
supports: SUPPORT
evidence_source: IN_VITRO
snippet: "we demonstrate that Coro1A promotes the deconstruction of F-actin density that facilitates effective delivery of lytic granules to the IS"
explanation: >-
Without coronin-1A-mediated F-actin deconstruction, lytic granules are
not delivered effectively to the immunological synapse.
evidence:
- reference: PMID:26476480
reference_title: "Recurrent viral infections associated with a homozygous CORO1A mutation that disrupts oligomerization and cytoskeletal association."
supports: SUPPORT
evidence_source: IN_VITRO
snippet: "The F-actin content of the patients’ CD4+ and CD8+ T cells was significantly higher than that of control T cells"
explanation: Measured F-actin excess in patient CD4+ and CD8+ T cells.
- reference: PMID:24760828
reference_title: "Lytic immune synapse function requires filamentous actin deconstruction by Coronin 1A."
supports: SUPPORT
evidence_source: IN_VITRO
snippet: "Coronin 1A (Coro1A) is the hematopoietic-specific member of the Coronin family of actin regulators that promote F-actin disassembly."
explanation: Coronin-1A's normal role is to promote F-actin disassembly.
- name: Impaired T-Cell Migration and Thymic Egress
biological_scale: CELLULAR
description: >-
Mature T cells lacking coronin-1A migrate poorly and are not efficiently
released from the thymus, so the thymus is present but peripheral output
is low. In patients this shows as very few recent thymic emigrants and
low T-cell receptor excision circles.
biological_processes:
- preferred_term: T cell migration
modifier: DECREASED
term:
id: GO:0072678
label: T cell migration
- preferred_term: thymocyte migration
modifier: DECREASED
term:
id: GO:0072679
label: thymocyte migration
cell_types:
- preferred_term: thymocyte
term:
id: CL:0000893
label: thymocyte
- preferred_term: T cell
term:
id: CL:0000084
label: T cell
downstream:
- target: Profound Naive and Innate-Like T-Cell Deficiency
causal_link_type: DIRECT
evidence:
- reference: PMID:26476480
reference_title: "Recurrent viral infections associated with a homozygous CORO1A mutation that disrupts oligomerization and cytoskeletal association."
supports: SUPPORT
evidence_source: IN_VITRO
snippet: "indicating that the patients’ CD4+ lymphopenia stemmed from defective T cell survival as well as decreased thymic output"
explanation: >-
Attributes the patients' CD4+ lymphopenia in part to decreased thymic
output.
- target: Abnormally low T cell receptor excision circle level
description: >-
Reduced thymic output means fewer recent thymic emigrants and hence few
T-cell receptor excision circles.
evidence:
- reference: PMID:18836449
reference_title: "The actin regulator coronin 1A is mutant in a thymic egress-deficient mouse strain and in a patient with severe combined immunodeficiency."
supports: SUPPORT
evidence_source: MODEL_ORGANISM
snippet: "Our findings establish a function for coronin 1A in T cell egress"
explanation: >-
Coronin-1A mutant mice establish the thymic egress function, which the
same paper connects to the human SCID patient.
- reference: PMID:19097825
reference_title: "Severe combined immunodeficiency (SCID) and attention deficit hyperactivity disorder (ADHD) associated with a Coronin-1A mutation and a chromosome 16p11.2 deletion."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "Murine Coronin-1A is essential for the release of T cells from the thymus, consistent with the paradoxically detectable thymus in our patient."
explanation: >-
A detectable thymus in a T-lymphopenic patient fits an egress block
rather than failed thymopoiesis.
- reference: PMID:26476480
reference_title: "Recurrent viral infections associated with a homozygous CORO1A mutation that disrupts oligomerization and cytoskeletal association."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "Quantification of CD4+CD31+CD45RA+ recent thymic emigrants in both patients demonstrated that CORO1ASer401fs severely impairs thymic output"
explanation: Direct measurement of low thymic output in patients.
- name: Reduced Peripheral T-Cell Survival
biological_scale: CELLULAR
description: >-
Patient CD4+ T cells show increased apoptosis at rest and after
stimulation, and re-expressing wild-type CORO1A in Coro1a-null mouse T
cells reduces their apoptosis. In mice the survival defect was attributed
to defective TCR-induced calcium mobilization; in patients with the S401fs
allele calcium flux was near normal, so calcium is not the whole
explanation (see the discussion below).
biological_processes:
- preferred_term: T cell apoptotic process
modifier: INCREASED
term:
id: GO:0070231
label: T cell apoptotic process
cell_types:
- preferred_term: T cell
term:
id: CL:0000084
label: T cell
downstream:
- target: Profound Naive and Innate-Like T-Cell Deficiency
causal_link_type: DIRECT
evidence:
- reference: PMID:26476480
reference_title: "Recurrent viral infections associated with a homozygous CORO1A mutation that disrupts oligomerization and cytoskeletal association."
supports: SUPPORT
evidence_source: IN_VITRO
snippet: "indicating that the patients’ CD4+ lymphopenia stemmed from defective T cell survival as well as decreased thymic output"
explanation: >-
Attributes the CD4+ lymphopenia in part to defective T-cell survival.
evidence:
- reference: PMID:26476480
reference_title: "Recurrent viral infections associated with a homozygous CORO1A mutation that disrupts oligomerization and cytoskeletal association."
supports: SUPPORT
evidence_source: IN_VITRO
snippet: "resting and PHA-stimulated CD4+ T cells in both siblings had increased Annexin V staining compared to control cells"
explanation: Increased apoptosis measured in patient CD4+ T cells.
- reference: PMID:26476480
reference_title: "Recurrent viral infections associated with a homozygous CORO1A mutation that disrupts oligomerization and cytoskeletal association."
supports: SUPPORT
evidence_source: IN_VITRO
snippet: "lentiviral transduction with WT CORO1A, but not the CORO1ASer401fs mutant, reduced apoptosis in CORO1A−/− T cells"
explanation: >-
Rescue of apoptosis by wild-type CORO1A in knockout T cells ties the
survival defect to coronin-1A function.
- reference: PMID:18345003
reference_title: "Regulation of T cell survival through coronin-1-mediated generation of inositol-1,4,5-trisphosphate and calcium mobilization after T cell receptor triggering."
supports: SUPPORT
evidence_source: MODEL_ORGANISM
snippet: "The absence of coronin-1, although it did not affect T cell development, resulted in a profound defect in Ca2+ mobilization, interleukin-2 production, T cell proliferation and T cell survival."
explanation: >-
Knockout mice show the survival defect; the calcium-mobilization
mechanism proposed here is not reproduced in patient cells with the
S401fs allele.
- name: Impaired NK-Cell Lytic Synapse Function
biological_scale: CELLULAR
description: >-
NK cells need coronin-1A to clear synaptic F-actin so that lytic granules
reach the target. NK cells from a coronin-1A-deficient patient and a
patient with a hemizygous missense allele had reduced cytotoxicity. The
S401fs siblings, whose truncated protein keeps its beta-propeller domain,
had normal NK killing, so this defect appears to depend on the allele.
biological_processes:
- preferred_term: natural killer cell mediated cytotoxicity
modifier: DECREASED
term:
id: GO:0042267
label: natural killer cell mediated cytotoxicity
cellular_components:
- preferred_term: immunological synapse
term:
id: GO:0001772
label: immunological synapse
cell_types:
- preferred_term: natural killer cell
term:
id: CL:0000623
label: natural killer cell
downstream:
- target: Failure of Immune Control of EBV-Infected B Cells
causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
evidence:
- reference: PMID:29225606
reference_title: "Epstein-Barr Virus-Specific Immune Control by Innate Lymphocytes."
supports: SUPPORT
directness: INDIRECT
evidence_source: HUMAN_CLINICAL
quote_role: REVIEW_SYNTHESIS
snippet: "several innate lymphocyte populations seem to target different stages of EBV infection and are compromised in primary immunodeficiencies that render individuals susceptible to symptomatic EBV infection"
explanation: >-
A review placing NK and other innate lymphocytes among the effectors of
EBV control that primary immunodeficiencies disable; not specific to
CORO1A, hence INDIRECT.
evidence:
- reference: PMID:24760828
reference_title: "Lytic immune synapse function requires filamentous actin deconstruction by Coronin 1A."
supports: SUPPORT
evidence_source: IN_VITRO
snippet: "Here, we show that Coro1A is required for natural killer (NK) cell cytotoxic function in two human NK cell lines and ex vivo cells from a Coro1A-deficient patient."
explanation: Reduced cytotoxicity in ex vivo NK cells from a patient.
- reference: PMID:37915722
reference_title: "Novel hemizygous CORO1A variant leads to combined immunodeficiency with defective platelet calcium signaling and cell mobility."
supports: SUPPORT
evidence_source: IN_VITRO
snippet: "The observed mutation resulted in impaired natural killer cell cytotoxicity and platelet calcium signaling."
explanation: A second patient allele with impaired NK cytotoxicity.
- reference: PMID:26476480
reference_title: "Recurrent viral infections associated with a homozygous CORO1A mutation that disrupts oligomerization and cytoskeletal association."
supports: REFUTE
evidence_source: IN_VITRO
snippet: "PBMCs from both patients demonstrated normal cytotoxic cell killing of K562 target cells at 4 hours"
explanation: >-
Contradicts a universal NK killing defect: patients with the C-terminal
S401fs allele had normal killing. The authors attribute this to the
retained beta-propeller domain, so the defect is allele-dependent.
- name: Profound Naive and Innate-Like T-Cell Deficiency
biological_scale: ORGANISM
description: >-
The defining immunological state: very low naive CD4+ and CD8+ T cells
with a restricted T-cell repertoire, near-absent invariant NKT cells and
severely reduced MAIT cells, while B-cell and NK-cell numbers are
relatively preserved in the index SCID patient. Hypomorphic alleles
produce the same naive T-cell defect with oligoclonal expansion of memory
T cells.
cell_types:
- preferred_term: naive CD4+ T cell
term:
id: CL:0000895
label: naive thymus-derived CD4-positive, alpha-beta T cell
- preferred_term: naive CD8+ T cell
term:
id: CL:0000900
label: naive thymus-derived CD8-positive, alpha-beta T cell
- preferred_term: invariant NKT cell
term:
id: CL:0000921
label: type I NK T cell
- preferred_term: mucosal-associated invariant T cell
term:
id: CL:0000940
label: mucosal-associated invariant T cell
biological_processes:
- preferred_term: T cell homeostasis
modifier: DECREASED
term:
id: GO:0043029
label: T cell homeostasis
downstream:
- target: Impaired Cell-Mediated Immunity to Viruses and Intracellular Pathogens
causal_link_type: DIRECT
evidence:
- reference: PMID:26476480
reference_title: "Recurrent viral infections associated with a homozygous CORO1A mutation that disrupts oligomerization and cytoskeletal association."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "Our studies demonstrate the importance of intact CORO1A C-terminal domains in thymic egress and T-cell survival, as well as in defense against viral pathogens."
explanation: >-
Links the thymic egress and T-cell survival defects to defective
antiviral defence in patients.
- target: Failure of Immune Control of EBV-Infected B Cells
causal_link_type: DIRECT
evidence:
- reference: PMID:25269405
reference_title: "The expanding spectrum of human coronin 1A deficiency."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
quote_role: REVIEW_SYNTHESIS
snippet: "hypomorphic mutations lead to a profound defect in naïve T cells, expansion of oligoclonal memory T cells, and exquisite susceptibility to EBV-associated B cell lymphoproliferation"
explanation: >-
A review pairing the naive T-cell defect with the characteristic EBV
susceptibility in patients with hypomorphic alleles.
- reference: PMID:26424649
reference_title: "Primary Immunodeficiencies Associated with EBV Disease."
supports: SUPPORT
directness: INDIRECT
evidence_source: HUMAN_CLINICAL
quote_role: REVIEW_SYNTHESIS
snippet: "EBV-infected B cells are controlled primarily by NK cells, iNKT cells, CD4 T cells, and CD8 T cells."
explanation: >-
General statement of which lymphocytes control EBV-infected B cells;
the T and iNKT populations lost in this disorder are among them.
- target: Impaired T-Cell-Dependent Humoral Immunity
causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
evidence:
- reference: PMID:18199416
reference_title: "The lupus-related Lmb3 locus contains a disease-suppressing Coronin-1A gene mutation."
supports: SUPPORT
directness: INDIRECT
evidence_source: MODEL_ORGANISM
snippet: "T-dependent humoral responses were impaired, but no intrinsic B cell defects were detected."
explanation: >-
In Coro1a nonsense-mutant mice the humoral defect is T-dependent, with
no intrinsic B-cell defect, which is the basis for routing the humoral
phenotypes through the T-cell deficiency. Mouse evidence, hence
INDIRECT.
- target: Severe combined immunodeficiency
- target: Decreased total T cell count
- target: Decreased naive CD4+ T cell proportion
- target: Abnormal TCR repertoire
- target: Decreased mucosal-associated invariant T cell proportion
evidence:
- reference: PMID:23522482
reference_title: "Whole-exome sequencing identifies Coronin-1A deficiency in 3 siblings with immunodeficiency and EBV-associated B-cell lymphoproliferation."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "In addition to a significant diminution of naive T-cell numbers, we found impaired development of a diverse T-cell repertoire, near-to-absent invariant natural killer T cells, and severely diminished mucosal-associated invariant T cell numbers."
explanation: >-
Documents every component of this node: naive T-cell loss, restricted
repertoire, and loss of iNKT and MAIT cells.
- reference: PMID:29942301
reference_title: "Inherited Immunodeficiencies With High Predisposition to Epstein-Barr Virus-Driven Lymphoproliferative Diseases."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
quote_role: REVIEW_SYNTHESIS
snippet: "Patients with CORO1A deficiency are characterized by a profound T cell lymphopenia with strongly decreased or nearly absent naïve cells associated with defective thymic output."
explanation: Review synthesis across the reported patients.
- name: Impaired Cell-Mediated Immunity to Viruses and Intracellular Pathogens
biological_scale: ORGANISM
description: >-
With few naive T cells, patients fail to contain viruses that are normally
held in check by T cells: varicella zoster (including vaccine strain),
beta-human papillomaviruses, molluscum contagiosum virus and herpes
simplex virus. One patient also developed tuberculoid leprosy, an
intracellular bacterial infection.
biological_processes:
- preferred_term: T cell mediated immunity
modifier: DECREASED
term:
id: GO:0002456
label: T cell mediated immunity
downstream:
- target: Recurrent viral infections
- target: Severe varicella zoster infection
- target: Post-vaccination varicella zoster virus infection
- target: Persistent beta-HPV infection with epidermodysplasia verruciformis-like lesions
evidence:
- reference: PMID:29946305
reference_title: "Epidermodysplasia Verruciformis: Inborn Errors of Immunity to Human Beta-Papillomaviruses."
supports: SUPPORT
directness: INDIRECT
evidence_source: HUMAN_CLINICAL
quote_role: REVIEW_SYNTHESIS
snippet: "the control of beta-HPV infections requires both EVER1/EVER2-dependent keratinocyte-intrinsic immunity and T cell-dependent adaptive immunity"
explanation: >-
Beta-HPV control needs T cell-dependent immunity, which this node says
is lost; the review covers inborn errors of T-cell immunity generally,
hence INDIRECT.
- target: Chronic warts
- target: Unusual molluscum contagiosum
- target: Unusual HSV skin infection
- target: Unusual mycobacterial skin infection
evidence:
- reference: PMID:26476480
reference_title: "Recurrent viral infections associated with a homozygous CORO1A mutation that disrupts oligomerization and cytoskeletal association."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "CORO1A deficiency causes T(-)B(+) natural killer-positive severe combined immunodeficiency or T-cell lymphopenia with severe viral infections."
explanation: Severe viral infection is the clinical expression of the T-cell defect.
- name: Impaired T-Cell-Dependent Humoral Immunity
biological_scale: ORGANISM
description: >-
Some patients have low memory B cells, hypogammaglobulinemia or poor
vaccine responses, and several have high IgE. The mouse data place the
defect in T-cell help rather than in B cells. It is not universal: the
S401fs siblings had normal immunoglobulins and specific antibody
responses.
cell_types:
- preferred_term: B cell
term:
id: CL:0000236
label: B cell
downstream:
- target: Decreased memory B cell proportion
- target: Decreased circulating immunoglobulin concentration
- target: Recurrent respiratory infections
causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
evidence:
- reference: PMID:29942301
reference_title: "Inherited Immunodeficiencies With High Predisposition to Epstein-Barr Virus-Driven Lymphoproliferative Diseases."
supports: SUPPORT
directness: INDIRECT
evidence_source: HUMAN_CLINICAL
quote_role: REVIEW_SYNTHESIS
snippet: "This may be related to the hypogammaglobulinemia and/or dysgammaglobulinemia associated with low number of CD27+ memory B cells that are frequently observed in these defects."
explanation: >-
The review relates the recurrent lung infections of this group of
EBV-susceptibility disorders, CORO1A deficiency among them, to their
humoral defect. It is hedged ("may be") and group-level, hence
INDIRECT.
- target: Recurrent bacterial infections
causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
description: >-
Hypogammaglobulinemia and impaired antibody responses predispose to
recurrent bacterial infection.
evidence:
- reference: PMID:29942301
reference_title: "Inherited Immunodeficiencies With High Predisposition to Epstein-Barr Virus-Driven Lymphoproliferative Diseases."
supports: SUPPORT
directness: INDIRECT
evidence_source: HUMAN_CLINICAL
quote_role: REVIEW_SYNTHESIS
snippet: "Bacterial infections, in particular recurrent lung infections are noticed in a number of patients and can be the initial clinical presentation."
explanation: >-
The review notes recurrent bacterial infections in this disorder group;
group-level and not CORO1A-specific, hence INDIRECT.
evidence:
- reference: PMID:18199416
reference_title: "The lupus-related Lmb3 locus contains a disease-suppressing Coronin-1A gene mutation."
supports: SUPPORT
evidence_source: MODEL_ORGANISM
snippet: "T-dependent humoral responses were impaired, but no intrinsic B cell defects were detected."
explanation: Mouse evidence that the humoral defect is T-cell dependent.
- reference: PMID:25073507
reference_title: "Compound heterozygous CORO1A mutations in siblings with a mucocutaneous-immunodeficiency syndrome of epidermodysplasia verruciformis-HPV, molluscum contagiosum and granulomatous tuberculoid leprosy."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "manifested as absent CD4CD45RA(+) (naïve) T and memory B cells, low NK cells"
explanation: Patients lacking memory B cells alongside naive T cells.
- name: Failure of Immune Control of EBV-Infected B Cells
biological_scale: ORGANISM
description: >-
EBV infection is normally held latent by cytotoxic T cells, NK cells and
iNKT cells. With these compromised, EBV-infected B cells proliferate.
Susceptibility to EBV-driven disease is the most consistent clinical
feature across CORO1A kindreds.
cell_types:
- preferred_term: B cell
term:
id: CL:0000236
label: B cell
downstream:
- target: EBV-Driven B-Cell Lymphoproliferation
causal_link_type: DIRECT
evidence:
- reference: PMID:29225606
reference_title: "Epstein-Barr Virus-Specific Immune Control by Innate Lymphocytes."
supports: SUPPORT
directness: INDIRECT
evidence_source: HUMAN_CLINICAL
quote_role: REVIEW_SYNTHESIS
snippet: "In most persistently EBV-infected individuals, potent cytotoxic lymphocyte responses prevent EBV-associated pathologies."
explanation: >-
General statement that cytotoxic lymphocyte control is what prevents
EBV pathology; when that control fails, as here, EBV-associated
pathology follows.
- target: Unusual EBV infection
evidence:
- reference: PMID:23522482
reference_title: "Whole-exome sequencing identifies Coronin-1A deficiency in 3 siblings with immunodeficiency and EBV-associated B-cell lymphoproliferation."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "Our findings define a new clinical entity of a primary immunodeficiency with increased susceptibility to EBV-induced lymphoproliferation in patients associated with hypomorphic Coronin-1A mutation."
explanation: Defines EBV susceptibility as a hallmark of the disorder.
- reference: PMID:29942301
reference_title: "Inherited Immunodeficiencies With High Predisposition to Epstein-Barr Virus-Driven Lymphoproliferative Diseases."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
quote_role: REVIEW_SYNTHESIS
snippet: "Among them are SH2D1A (SAP), XIAP, ITK, MAGT1, CD27, CD70, CTPS1, RASGRP1, and CORO1A deficiencies."
explanation: >-
Lists CORO1A deficiency among the inherited disorders with a high risk of
EBV-associated lymphoproliferative disease.
- name: EBV-Driven B-Cell Lymphoproliferation
biological_scale: TISSUE
description: >-
EBV-positive B-cell lymphoproliferative disease and B-cell lymphoma, often
in early childhood and in several cases fatal.
cell_types:
- preferred_term: B cell
term:
id: CL:0000236
label: B cell
downstream:
- target: Lymphoproliferative disorder
- target: B-cell lymphoma
evidence:
- reference: PMID:23522482
reference_title: "Whole-exome sequencing identifies Coronin-1A deficiency in 3 siblings with immunodeficiency and EBV-associated B-cell lymphoproliferation."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "We evaluated 3 siblings from a consanguineous family presenting with EBV-associated B-cell lymphoproliferation at an early age"
explanation: EBV-associated B-cell lymphoproliferation in three affected siblings.
- reference: PMID:25073507
reference_title: "Compound heterozygous CORO1A mutations in siblings with a mucocutaneous-immunodeficiency syndrome of epidermodysplasia verruciformis-HPV, molluscum contagiosum and granulomatous tuberculoid leprosy."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "the female died of EBV+ lymphomas at age 16 years"
explanation: A fatal EBV-positive lymphoma in a second kindred.
- name: Co-occurring 16p11.2 Contiguous Gene Deletion
biological_scale: MOLECULAR
description: >-
In at least two patients the second CORO1A allele was removed by a
16p11.2 microdeletion that also deletes neighbouring genes. The
neurodevelopmental features of the deletion are a contiguous-gene effect
and are not attributed to coronin-1A loss.
genetic_context:
variant_origin: GERMLINE
functional_impact_category: LOSS_OF_FUNCTION
downstream:
- target: Biallelic CORO1A Loss-of-Function Variants
causal_link_type: DIRECT
description: >-
The deletion removes CORO1A on one chromosome and so supplies one of the
two deficient alleles.
- target: Cognitive impairment
causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
description: >-
Candidate explanation only. At least two patients carried the 16p11.2
deletion, but the review reporting cognitive impairment in 3 of 9 patients
does not say which patients were affected, so the contribution of the
deletion versus coronin-1A loss is not established.
- target: Attention deficit hyperactivity disorder
causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
evidence:
- reference: PMID:19097825
reference_title: "Severe combined immunodeficiency (SCID) and attention deficit hyperactivity disorder (ADHD) associated with a Coronin-1A mutation and a chromosome 16p11.2 deletion."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "This genomic region at 16p11.2 is subject to recurrent copy number variations associated with autism spectrum disorders, including attention deficit and hyperactivity, present in our patient."
explanation: >-
The authors link the patient's attention deficit and hyperactivity to
the 16p11.2 copy number variation.
evidence:
- reference: PMID:19097825
reference_title: "Severe combined immunodeficiency (SCID) and attention deficit hyperactivity disorder (ADHD) associated with a Coronin-1A mutation and a chromosome 16p11.2 deletion."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "a 600 kb de novo deletion encompassing CORO1A on the maternal allele"
explanation: The deletion that forms one CORO1A allele in the first reported patient.
- reference: PMID:37915722
reference_title: "Novel hemizygous CORO1A variant leads to combined immunodeficiency with defective platelet calcium signaling and cell mobility."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "in combination with a de novo heterozygous microdeletion of chromosome 16p11.2"
explanation: A second patient in whom a 16p11.2 microdeletion accompanies the CORO1A variant.
phenotypes:
- category: Immune
name: Severe combined immunodeficiency
description: >-
The index patient had T-B+NK+ SCID. Later patients with hypomorphic or
C-terminal alleles have a combined immunodeficiency presenting later in
childhood or young adulthood, so SCID is the severe end of the spectrum
rather than a constant feature.
phenotype_term:
preferred_term: T-B+NK+ severe combined immunodeficiency
term:
id: HP:0004430
label: Severe combined immunodeficiency
evidence:
- reference: PMID:19097825
reference_title: "Severe combined immunodeficiency (SCID) and attention deficit hyperactivity disorder (ADHD) associated with a Coronin-1A mutation and a chromosome 16p11.2 deletion."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "we identified absence of Coronin-1A in a girl with T-B+NK+ SCID who suffered recurrent infections including severe post-vaccination varicella at age 13 months"
explanation: The founding patient's T-B+NK+ SCID phenotype.
- reference: DOI:10.14785/lymphosign-2019-0004
reference_title: "Successful hematopoietic stem cell transplantation in a patient with a novel mutation in coronin 1A"
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "Null mutations in coronin 1A result in severe combined immunodeficiency, whereas hypomorphic mutations have been associated with a somewhat milder immunological phenotype."
explanation: >-
States the allele-dependent spectrum: SCID with null alleles, milder
combined immunodeficiency with hypomorphic ones.
- category: Immune
name: Decreased total T cell count
phenotype_term:
preferred_term: T-cell lymphopenia
term:
id: HP:0005403
label: Decreased total T cell count
evidence:
- reference: PMID:18836449
reference_title: "The actin regulator coronin 1A is mutant in a thymic egress-deficient mouse strain and in a patient with severe combined immunodeficiency."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "a T cell-deficient, B cell-sufficient and natural killer cell-sufficient patient with severe combined immunodeficiency"
explanation: T-cell deficiency with preserved B and NK cells in the index patient.
- category: Immune
name: Decreased total CD4+ T cell count
frequency: VERY_FREQUENT
description: >-
Reduced CD4+ T cells were recorded in 8 of 9 patients in a 2018 review
table.
phenotype_term:
preferred_term: CD4+ T-cell lymphopenia
term:
id: HP:5210418
label: Decreased total CD4+ T cell count
reports_on:
- target: Profound Naive and Innate-Like T-Cell Deficiency
relationship: READOUT_OF
description: The CD4+ count is a direct laboratory readout of the T-cell deficiency.
evidence:
- reference: PMID:26476480
reference_title: "Recurrent viral infections associated with a homozygous CORO1A mutation that disrupts oligomerization and cytoskeletal association."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "Both patients had CD4(+) T-cell lymphopenia and decreased lymphocyte proliferation to mitogens."
explanation: CD4+ lymphopenia in both affected siblings.
- reference: PMID:29942301
reference_title: "Inherited Immunodeficiencies With High Predisposition to Epstein-Barr Virus-Driven Lymphoproliferative Diseases."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
quote_role: REVIEW_SYNTHESIS
snippet: "↓ CD4+ 8/9 ↓ MAIT 1/1 ↓ iNKT 1/1"
explanation: >-
From the CORO1A row of the review's Table 1 (n = 9): reduced CD4+ T cells
in 8 of 9, supporting VERY_FREQUENT.
- category: Immune
name: Decreased naive CD4+ T cell proportion
phenotype_term:
preferred_term: Absent or reduced naive CD4+ T cells
term:
id: HP:0410378
label: Decreased naive CD4+ T cell proportion
evidence:
- reference: PMID:25073507
reference_title: "Compound heterozygous CORO1A mutations in siblings with a mucocutaneous-immunodeficiency syndrome of epidermodysplasia verruciformis-HPV, molluscum contagiosum and granulomatous tuberculoid leprosy."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "manifested as absent CD4CD45RA(+) (naïve) T and memory B cells, low NK cells"
explanation: Absent naive (CD45RA+) CD4+ T cells in both siblings.
- reference: DOI:10.14785/lymphosign-2019-0001
reference_title: "Coronin 1A deficiency identified by newborn screening for severe combined immunodeficiency"
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "The patient presented with T cell lymphopenia, reduction in CD4+CD45Ra+ cells and hypogammaglobulinemia."
explanation: Reduced naive CD4+ T cells in a newborn-screened patient.
- category: Immune
name: Abnormally low T cell receptor excision circle level
description: Low TRECs make the disorder detectable by TREC-based newborn SCID screening.
phenotype_term:
preferred_term: Low T-cell receptor excision circles
term:
id: HP:0031545
label: Abnormally low T cell receptor excision circle level
diagnostic: true
evidence:
- reference: DOI:10.14785/lymphosign-2019-0004
reference_title: "Successful hematopoietic stem cell transplantation in a patient with a novel mutation in coronin 1A"
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "Lymphocyte responses to mitogens and T cell receptor excision circle levels were markedly reduced, consistent with the diagnosis of severe combined immunodeficiency."
explanation: Markedly reduced TRECs in a patient.
- reference: DOI:10.14785/lymphosign-2019-0001
reference_title: "Coronin 1A deficiency identified by newborn screening for severe combined immunodeficiency"
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "Coronin 1A deficiency can be detected after birth by T cell receptor excision circle-based newborn screening."
explanation: Low TRECs led to detection by newborn screening.
- category: Immune
name: Abnormal TCR repertoire
phenotype_term:
preferred_term: Restricted T-cell receptor repertoire
term:
id: HP:0025845
label: Abnormal TCR repertoire
evidence:
- reference: PMID:23522482
reference_title: "Whole-exome sequencing identifies Coronin-1A deficiency in 3 siblings with immunodeficiency and EBV-associated B-cell lymphoproliferation."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "we found impaired development of a diverse T-cell repertoire"
explanation: Impaired T-cell repertoire diversity in patients.
- category: Immune
name: Decreased mucosal-associated invariant T cell proportion
description: >-
MAIT cells are severely reduced and invariant NKT cells near-absent. HPO
has no term for iNKT deficiency, so the iNKT loss is carried in this
description and in the pathophysiology node's cell types.
phenotype_term:
preferred_term: Decreased MAIT and iNKT cells
term:
id: HP:4000039
label: Decreased mucosal-associated invariant T cell proportion
evidence:
- reference: PMID:23522482
reference_title: "Whole-exome sequencing identifies Coronin-1A deficiency in 3 siblings with immunodeficiency and EBV-associated B-cell lymphoproliferation."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "near-to-absent invariant natural killer T cells, and severely diminished mucosal-associated invariant T cell numbers"
explanation: Loss of both innate-like T-cell populations.
- category: Immune
name: Decreased mitogen-induced T-cell proliferation
phenotype_term:
preferred_term: Decreased T-cell proliferation to mitogens
term:
id: HP:0031381
label: Decreased mitogen-induced T-cell proliferation
reports_on:
- target: Profound Naive and Innate-Like T-Cell Deficiency
relationship: READOUT_OF
description: A functional laboratory readout of the T-cell compartment.
evidence:
- reference: PMID:26476480
reference_title: "Recurrent viral infections associated with a homozygous CORO1A mutation that disrupts oligomerization and cytoskeletal association."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "Both patients had CD4(+) T-cell lymphopenia and decreased lymphocyte proliferation to mitogens."
explanation: Reduced mitogen proliferation in both siblings.
- category: Immune
name: Increased double-negative T cell number
phenotype_term:
preferred_term: Increased double-negative gamma-delta T cells
term:
id: HP:0002851
label: Increased double-negative T cell number
reports_on:
- target: Profound Naive and Innate-Like T-Cell Deficiency
relationship: READOUT_OF
description: A feature of the disturbed T-cell compartment.
evidence:
- reference: PMID:25073507
reference_title: "Compound heterozygous CORO1A mutations in siblings with a mucocutaneous-immunodeficiency syndrome of epidermodysplasia verruciformis-HPV, molluscum contagiosum and granulomatous tuberculoid leprosy."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "low NK cells and abnormally increased double-negative (DN)"
explanation: >-
Increased double-negative T cells (gamma-delta, per the full sentence) in
the compound heterozygous siblings.
- category: Immune
name: Decreased memory B cell proportion
phenotype_term:
preferred_term: Absent memory B cells
term:
id: HP:0030374
label: Decreased memory B cell proportion
evidence:
- reference: PMID:25073507
reference_title: "Compound heterozygous CORO1A mutations in siblings with a mucocutaneous-immunodeficiency syndrome of epidermodysplasia verruciformis-HPV, molluscum contagiosum and granulomatous tuberculoid leprosy."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "manifested as absent CD4CD45RA(+) (naïve) T and memory B cells"
explanation: Absent memory B cells in the compound heterozygous siblings.
- category: Immune
name: Decreased circulating immunoglobulin concentration
description: >-
Hypogammaglobulinemia is reported in several patients but not all; the
S401fs siblings had normal IgG, IgM, IgA and specific antibody responses.
phenotype_term:
preferred_term: Hypogammaglobulinemia
term:
id: HP:0004313
label: Decreased circulating immunoglobulin concentration
evidence:
- reference: DOI:10.14785/lymphosign-2019-0001
reference_title: "Coronin 1A deficiency identified by newborn screening for severe combined immunodeficiency"
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "The patient presented with T cell lymphopenia, reduction in CD4+CD45Ra+ cells and hypogammaglobulinemia."
explanation: Hypogammaglobulinemia in a newborn-screened patient.
- reference: PMID:40464874
reference_title: "A rare case of coronin-1A deficiency with IgM dominant membranoproliferative glomerulonephritis."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
quote_role: BACKGROUND
snippet: "This condition presents with lymphopenia, hypogammaglobulinemia, recurrent Epstein-Barr virus (EBV) infections, EBV-associated B-cell lymphoma and epidermodysplasia verruciformis."
explanation: >-
Background summary of the disorder in a case report, listing
hypogammaglobulinemia among its features.
- category: Immune
name: Increased circulating IgE concentration
frequency: VERY_FREQUENT
description: >-
High IgE in 4 of the 5 patients in whom it was recorded in a 2018 review
table; the denominator is small.
phenotype_term:
preferred_term: Elevated IgE
term:
id: HP:0003212
label: Increased circulating IgE concentration
reports_on:
- target: Impaired T-Cell-Dependent Humoral Immunity
relationship: READOUT_OF
description: A marker of disturbed B-cell regulation; the mechanism is not established.
evidence:
- reference: PMID:29942301
reference_title: "Inherited Immunodeficiencies With High Predisposition to Epstein-Barr Virus-Driven Lymphoproliferative Diseases."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
quote_role: REVIEW_SYNTHESIS
snippet: "↓ iNKT 1/1 | High IgE level 4/5"
explanation: >-
CORO1A row of the review's Table 1: high IgE in 4 of 5 patients tested.
- category: Immune
name: Decreased natural killer cell-induced killing of target cells
description: >-
Reduced NK cytotoxicity in a coronin-1A-deficient patient and a
hemizygous-variant patient; normal in the S401fs siblings.
phenotype_term:
preferred_term: Impaired NK-cell cytotoxicity
term:
id: HP:0025808
label: Decreased natural killer cell-induced killing of target cells
reports_on:
- target: Impaired NK-Cell Lytic Synapse Function
relationship: READOUT_OF
description: The cytotoxicity assay is the direct readout of this node.
evidence:
- reference: PMID:24760828
reference_title: "Lytic immune synapse function requires filamentous actin deconstruction by Coronin 1A."
supports: SUPPORT
evidence_source: IN_VITRO
snippet: "Here, we show that Coro1A is required for natural killer (NK) cell cytotoxic function in two human NK cell lines and ex vivo cells from a Coro1A-deficient patient."
explanation: Defective killing by ex vivo patient NK cells.
- category: Immune
name: Recurrent viral infections
phenotype_term:
preferred_term: Severe and recurrent viral infections
term:
id: HP:0004429
label: Recurrent viral infections
evidence:
- reference: PMID:26476480
reference_title: "Recurrent viral infections associated with a homozygous CORO1A mutation that disrupts oligomerization and cytoskeletal association."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "CORO1A deficiency causes T(-)B(+) natural killer-positive severe combined immunodeficiency or T-cell lymphopenia with severe viral infections."
explanation: Severe viral infection is a defining feature.
- category: Immune
name: Severe varicella zoster infection
frequency: FREQUENT
description: Disseminated varicella; VZV infection in 5 of 9 patients in a 2018 review table.
phenotype_term:
preferred_term: Severe or disseminated varicella
term:
id: HP:0032170
label: Severe varicella zoster infection
evidence:
- reference: PMID:26476480
reference_title: "Recurrent viral infections associated with a homozygous CORO1A mutation that disrupts oligomerization and cytoskeletal association."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "2 young adult siblings with a history of disseminated varicella, cutaneous warts, and CD4(+) T-cell lymphopenia"
explanation: Disseminated varicella in the S401fs sibship.
- reference: PMID:29942301
reference_title: "Inherited Immunodeficiencies With High Predisposition to Epstein-Barr Virus-Driven Lymphoproliferative Diseases."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
quote_role: REVIEW_SYNTHESIS
snippet: "EBV 5/9 HPV 4/9, VZV 5/9 HSV 2/9 Parvovirus B19 1/9"
explanation: >-
CORO1A row of the review's Table 1: VZV infection in 5 of 9 patients,
supporting the FREQUENT band.
- category: Immune
name: Post-vaccination varicella zoster virus infection
phenotype_term:
preferred_term: Severe post-vaccination varicella
term:
id: HP:4000166
label: Post-vaccination varicella zoster virus infection
evidence:
- reference: PMID:19097825
reference_title: "Severe combined immunodeficiency (SCID) and attention deficit hyperactivity disorder (ADHD) associated with a Coronin-1A mutation and a chromosome 16p11.2 deletion."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "severe post-vaccination varicella at age 13 months"
explanation: The index patient's severe reaction to varicella vaccine.
- category: Integument
name: Persistent beta-HPV infection with epidermodysplasia verruciformis-like lesions
frequency: FREQUENT
description: >-
An epidermodysplasia verruciformis-like syndrome with disseminated flat
warts and pityriasis versicolor-like lesions from beta-HPV, particularly in
patients with hypomorphic or compound heterozygous alleles; HPV in 4 of 9
patients in a 2018 review table.
phenotype_term:
preferred_term: Persistent human papillomavirus infection
term:
id: HP:0020114
label: Persistent human papillomavirus infection
evidence:
- reference: PMID:25073507
reference_title: "Compound heterozygous CORO1A mutations in siblings with a mucocutaneous-immunodeficiency syndrome of epidermodysplasia verruciformis-HPV, molluscum contagiosum and granulomatous tuberculoid leprosy."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "Distinguishing characteristics were late clinical debut with an unusual mucocutaneous syndrome of epidermodysplasia verruciformis-human papilloma virus (EV-HPV)"
explanation: The EV-HPV mucocutaneous syndrome in the compound heterozygous siblings.
- reference: PMID:29942301
reference_title: "Inherited Immunodeficiencies With High Predisposition to Epstein-Barr Virus-Driven Lymphoproliferative Diseases."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
quote_role: REVIEW_SYNTHESIS
snippet: "Four patients had severe mucocutaneous-immunodeficiency manifestations including epidermodysplasia verruciformis-HPV (EV-HPV)"
explanation: EV-HPV in 4 patients in the review, supporting FREQUENT.
- category: Integument
name: Chronic warts
phenotype_term:
preferred_term: Chronic cutaneous warts
term:
id: HP:5210306
label: Chronic warts
evidence:
- reference: PMID:26476480
reference_title: "Recurrent viral infections associated with a homozygous CORO1A mutation that disrupts oligomerization and cytoskeletal association."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "2 young adult siblings with a history of disseminated varicella, cutaneous warts, and CD4(+) T-cell lymphopenia"
explanation: Chronic cutaneous warts in the S401fs siblings.
- category: Integument
name: Unusual molluscum contagiosum
phenotype_term:
preferred_term: Molluscum contagiosum
term:
id: HP:0032163
label: Unusual molluscum contagiosum
evidence:
- reference: PMID:25073507
reference_title: "Compound heterozygous CORO1A mutations in siblings with a mucocutaneous-immunodeficiency syndrome of epidermodysplasia verruciformis-HPV, molluscum contagiosum and granulomatous tuberculoid leprosy."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "an unusual mucocutaneous syndrome of epidermodysplasia verruciformis-human papilloma virus (EV-HPV), molluscum contagiosum and oral-cutaneous herpetic ulcers"
explanation: Molluscum contagiosum in the compound heterozygous siblings.
- category: Integument
name: Unusual HSV skin infection
phenotype_term:
preferred_term: Oral-cutaneous herpes simplex ulcers
term:
id: HP:5210233
label: Unusual HSV skin infection
evidence:
- reference: PMID:25073507
reference_title: "Compound heterozygous CORO1A mutations in siblings with a mucocutaneous-immunodeficiency syndrome of epidermodysplasia verruciformis-HPV, molluscum contagiosum and granulomatous tuberculoid leprosy."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "molluscum contagiosum and oral-cutaneous herpetic ulcers"
explanation: Oral-cutaneous HSV-1 ulcers in the compound heterozygous siblings.
- category: Integument
name: Unusual mycobacterial skin infection
description: >-
A single patient developed granulomatous tuberculoid leprosy; recorded as
an isolated observation.
phenotype_term:
preferred_term: Granulomatous tuberculoid leprosy
term:
id: HP:5210242
label: Unusual mycobacterial skin infection
evidence:
- reference: PMID:25073507
reference_title: "Compound heterozygous CORO1A mutations in siblings with a mucocutaneous-immunodeficiency syndrome of epidermodysplasia verruciformis-HPV, molluscum contagiosum and granulomatous tuberculoid leprosy."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "the older female sibling also had a disfiguring granulomatous tuberculoid leprosy"
explanation: Tuberculoid leprosy in one sibling.
- category: Immune
name: Unusual EBV infection
description: >-
Inability to control EBV, with chronic infection preceding lymphoproliferative
disease.
phenotype_term:
preferred_term: Uncontrolled EBV infection
term:
id: HP:5210286
label: Unusual EBV infection
evidence:
- reference: PMID:29942301
reference_title: "Inherited Immunodeficiencies With High Predisposition to Epstein-Barr Virus-Driven Lymphoproliferative Diseases."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
quote_role: REVIEW_SYNTHESIS
snippet: "EBV 5/9 HPV 4/9, VZV 5/9 HSV 2/9 Parvovirus B19 1/9"
explanation: EBV infection in 5 of 9 patients in the review's CORO1A row.
- category: Neoplasm
name: Lymphoproliferative disorder
phenotype_term:
preferred_term: EBV-associated lymphoproliferative disorder
term:
id: HP:0005523
label: Lymphoproliferative disorder
evidence:
- reference: PMID:23522482
reference_title: "Whole-exome sequencing identifies Coronin-1A deficiency in 3 siblings with immunodeficiency and EBV-associated B-cell lymphoproliferation."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "EBV-associated B-cell lymphoproliferation at an early age"
explanation: EBV-associated lymphoproliferation in the affected siblings.
- category: Neoplasm
name: B-cell lymphoma
frequency: FREQUENT
description: >-
EBV-positive B-cell lymphoma; lymphoproliferative disorder or B lymphoma in
5 of 9 patients in a 2018 review table.
phenotype_term:
preferred_term: EBV-positive B-cell lymphoma
term:
id: HP:0012191
label: B-cell lymphoma
evidence:
- reference: PMID:25073507
reference_title: "Compound heterozygous CORO1A mutations in siblings with a mucocutaneous-immunodeficiency syndrome of epidermodysplasia verruciformis-HPV, molluscum contagiosum and granulomatous tuberculoid leprosy."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "the female died of EBV+ lymphomas at age 16 years"
explanation: A fatal EBV-positive B-cell lymphoma.
- reference: PMID:29942301
reference_title: "Inherited Immunodeficiencies With High Predisposition to Epstein-Barr Virus-Driven Lymphoproliferative Diseases."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
quote_role: REVIEW_SYNTHESIS
snippet: "Patients presented with severe infections, and five developed EBV-driven B cell lymphoma."
explanation: >-
Review statement that 5 of the 9 reported CORO1A patients developed
EBV-driven B-cell lymphoma, supporting the FREQUENT band.
- category: Respiratory
name: Recurrent respiratory infections
frequency: FREQUENT
description: >-
Recurrent respiratory and ENT infections; lung infections in 7 of 9
patients in a 2018 review table.
phenotype_term:
preferred_term: Recurrent respiratory infections
term:
id: HP:0002205
label: Recurrent respiratory infections
sequelae:
- target: Bronchiectasis
causal_link_type: DIRECT
description: >-
Repeated lower respiratory infection causes the structural airway damage
of bronchiectasis.
evidence:
- reference: PMID:29942301
reference_title: "Inherited Immunodeficiencies With High Predisposition to Epstein-Barr Virus-Driven Lymphoproliferative Diseases."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
quote_role: REVIEW_SYNTHESIS
snippet: "Lung infections 7/9 Cutaneous leprosy 1/9 Visceral leishmaniasis 1/9"
explanation: Lung infections in 7 of 9 patients in the review's CORO1A row.
- category: Respiratory
name: Bronchiectasis
description: Structural lung damage from recurrent respiratory infection.
phenotype_term:
preferred_term: Bronchiectasis
term:
id: HP:0002110
label: Bronchiectasis
evidence:
- reference: PMID:25073507
reference_title: "Compound heterozygous CORO1A mutations in siblings with a mucocutaneous-immunodeficiency syndrome of epidermodysplasia verruciformis-HPV, molluscum contagiosum and granulomatous tuberculoid leprosy."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "Both had bilateral bronchiectasis and the female died of EBV+ lymphomas at age 16 years."
explanation: Bilateral bronchiectasis in both compound heterozygous siblings.
- category: Immune
name: Recurrent bacterial infections
description: >-
Recurrent bacterial infections, including recurrent pneumonia, in some
patients.
phenotype_term:
preferred_term: Recurrent bacterial infections
term:
id: HP:0002718
label: Recurrent bacterial infections
evidence:
- reference: PMID:42318436
reference_title: "A Novel Variant of CORO1A Gene Contributing to the Development of Primary Immunodeficiency in Children."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "Her past medical history was remarkable for multiple hospital admissions secondary to community-acquired pneumonia and urinary tract infections"
explanation: Recurrent bacterial infections in a patient with a novel CORO1A variant.
- category: Blood
name: Decreased total neutrophil count
description: >-
Neutropenia is an unusual finding, reported in a newborn-screened patient.
phenotype_term:
preferred_term: Neutropenia
term:
id: HP:0001875
label: Decreased total neutrophil count
evidence:
- reference: DOI:10.14785/lymphosign-2019-0001
reference_title: "Coronin 1A deficiency identified by newborn screening for severe combined immunodeficiency"
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "Uniquely, she also had persistent severe neutropenia."
explanation: Persistent severe neutropenia, described as a unique finding.
- category: Nervous System
name: Attention deficit hyperactivity disorder
description: >-
Reported in one patient and attributed by the authors to her 16p11.2
contiguous-gene deletion rather than to coronin-1A loss; modeled through the
contiguous-gene deletion node.
phenotype_term:
preferred_term: Attention deficit hyperactivity disorder
term:
id: HP:0007018
label: Attention deficit hyperactivity disorder
evidence:
- reference: PMID:19097825
reference_title: "Severe combined immunodeficiency (SCID) and attention deficit hyperactivity disorder (ADHD) associated with a Coronin-1A mutation and a chromosome 16p11.2 deletion."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "This genomic region at 16p11.2 is subject to recurrent copy number variations associated with autism spectrum disorders, including attention deficit and hyperactivity, present in our patient."
explanation: ADHD attributed to the 16p11.2 copy number variation.
- category: Nervous System
name: Cognitive impairment
description: >-
Neurological involvement, reported as cognitive impairment, in 3 of the 9
patients summarised in a 2018 review, including autism-like symptoms. The
review does not identify which patients were affected, and at least two
reported patients carry a 16p11.2 contiguous-gene deletion that is itself
associated with neurodevelopmental disorders, so whether coronin-1A loss
contributes is unresolved.
phenotype_term:
preferred_term: Cognitive impairment
term:
id: HP:0100543
label: Cognitive impairment
frequency: FREQUENT
evidence:
- reference: PMID:29942301
reference_title: "Inherited Immunodeficiencies With High Predisposition to Epstein-Barr Virus-Driven Lymphoproliferative Diseases."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
quote_role: REVIEW_SYNTHESIS
snippet: "Neurological involvement (cognitive impairment) 3/9"
explanation: >-
The review's CORO1A table row: cognitive impairment in 3 of 9 patients
(33%), supporting the FREQUENT band.
- reference: PMID:29942301
reference_title: "Inherited Immunodeficiencies With High Predisposition to Epstein-Barr Virus-Driven Lymphoproliferative Diseases."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
quote_role: REVIEW_SYNTHESIS
snippet: "Three patients also exhibited neurological abnormalities including autism-like symptoms."
explanation: The review's text on the same three patients, including autism-like features.
- category: Blood
name: Short telomere length
description: >-
Very short telomeres were found in one surviving patient; a single
observation not previously reported in CORO1A deficiency.
phenotype_term:
preferred_term: Short telomeres
term:
id: HP:0031413
label: Short telomere length
evidence:
- reference: PMID:25073507
reference_title: "Compound heterozygous CORO1A mutations in siblings with a mucocutaneous-immunodeficiency syndrome of epidermodysplasia verruciformis-HPV, molluscum contagiosum and granulomatous tuberculoid leprosy."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "The younger surviving male, without malignancy, had reproducibly very short telomere lengths, not before appreciated in CORO1A mutations."
explanation: Very short telomeres in one patient, noted as a novel finding.
genetic:
- name: CORO1A
gene_term:
preferred_term: CORO1A
term:
id: hgnc:2252
label: CORO1A
relationship_type: CAUSATIVE
variant_origin: GERMLINE
inheritance:
- name: Autosomal recessive
inheritance_term:
preferred_term: Autosomal recessive inheritance
term:
id: HP:0000007
label: Autosomal recessive inheritance
notes: >-
CORO1A (16p11.2) encodes coronin-1A, an actin regulator expressed mainly in
haematopoietic cells. Reported disease alleles are frameshift truncations
(p.P83RfsX10, p.Q360RfsX44), a beta-propeller missense that abolishes
expression (p.V134M), whole-gene deletion within a 16p11.2 microdeletion,
and a C-terminal frameshift (p.S401fs) that is expressed but cannot
oligomerize. All are loss of function; heterozygous carriers are unaffected.
evidence:
- reference: PMID:18836449
reference_title: "The actin regulator coronin 1A is mutant in a thymic egress-deficient mouse strain and in a patient with severe combined immunodeficiency."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "a T cell-deficient, B cell-sufficient and natural killer cell-sufficient patient with severe combined immunodeficiency, whom we found had mutations in both CORO1A alleles"
explanation: Establishes CORO1A as the causative gene in the index patient.
- reference: PMID:23522482
reference_title: "Whole-exome sequencing identifies Coronin-1A deficiency in 3 siblings with immunodeficiency and EBV-associated B-cell lymphoproliferation."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "We identified a homozygous inherited missense mutation in the gene encoding Coronin-1A (CORO1A) in the 3 siblings."
explanation: Independent identification of a causative CORO1A allele.
animal_models:
- name: Coronin-1A knockout mouse
species: Mouse
genotype: Coro1a-/-
publication: PMID:16902139
description: >-
Germline Coro1a-null mice have profound peripheral T-cell lymphopenia with
impaired chemokine-directed migration and disturbed lymphocyte homeostasis,
while T-cell receptor functions are relatively spared. The model reproduces
the human peripheral T-cell deficiency and the migration lesion.
modeled_mechanisms:
- target: Impaired T-Cell Migration and Thymic Egress
relationship: RECAPITULATES
fidelity: MODERATE
model_scale: CELLULAR
description: >-
Coronin 1-deficient T cells fail chemokine-mediated migration, the same
defect proposed to block thymic egress in patients.
limitations: >-
The mouse reproduces the T-cell migration and homeostasis defect but not
the human-specific viral complications (EBV lymphoproliferation, beta-HPV
disease), whose viruses do not infect mice.
readouts:
- name: Chemokine-mediated T-cell migration
target: Impaired T-Cell Migration and Thymic Egress
direction: DECREASED
interpretation: Migration defect corresponding to the human egress block.
evidence:
- reference: PMID:16902139
reference_title: "Requirement for coronin 1 in T lymphocyte trafficking and cellular homeostasis."
supports: SUPPORT
evidence_source: MODEL_ORGANISM
snippet: "coronin 1 was required for chemokine-mediated migration"
explanation: The measured migration defect in knockout T cells.
evidence:
- reference: PMID:16902139
reference_title: "Requirement for coronin 1 in T lymphocyte trafficking and cellular homeostasis."
supports: SUPPORT
evidence_source: MODEL_ORGANISM
snippet: "coronin 1 was required for chemokine-mediated migration, it was dispensable for T cell antigen receptor functions in T cells"
explanation: >-
Establishes the model as informative for the migration node, with the
TCR-sparing pattern seen in patients.
- target: Reduced Peripheral T-Cell Survival
relationship: RECAPITULATES
fidelity: MODERATE
model_scale: CELLULAR
description: >-
Coro1a-null T cells survive poorly; the defect was attributed to impaired
TCR-induced calcium mobilization, which is where the mouse and the human
S401fs data diverge (see the discussion).
limitations: >-
The calcium-mobilization mechanism proposed in mice is not reproduced in
patients with the C-terminal S401fs allele, whose calcium flux is near
normal. The mouse mechanism may therefore be allele- or species-specific.
divergences:
- divergence_type: SPECIES_MISMATCH
materiality: QUALIFYING
description: >-
Coro1a-null mouse T cells show a profound calcium-mobilization defect
driving apoptosis, whereas patient T cells carrying the S401fs allele
have near-normal calcium flux with the same survival defect, so the
murine calcium mechanism does not transfer to that human allele.
evidence:
- reference: PMID:18345003
reference_title: "Regulation of T cell survival through coronin-1-mediated generation of inositol-1,4,5-trisphosphate and calcium mobilization after T cell receptor triggering."
supports: SUPPORT
evidence_source: MODEL_ORGANISM
snippet: "The absence of coronin-1, although it did not affect T cell development, resulted in a profound defect in Ca2+ mobilization, interleukin-2 production, T cell proliferation and T cell survival."
explanation: The murine survival defect and its proposed calcium mechanism.
evidence:
- reference: PMID:16902139
reference_title: "Requirement for coronin 1 in T lymphocyte trafficking and cellular homeostasis."
supports: SUPPORT
evidence_source: MODEL_ORGANISM
snippet: "We generated coronin 1-/- mice and found that coronin 1 exerted an inhibitory effect on cellular steady-state F-actin formation via an Arp2/3-dependent mechanism."
explanation: Attests the model recapitulates the core actin-regulatory lesion.
treatments:
- name: Allogeneic hematopoietic stem cell transplantation
description: >-
The only curative therapy. Because the defect is intrinsic to
haematopoietic cells, donor stem cells reconstitute T-cell numbers and
function; two long-term successful transplants are documented, and it is
proposed as an immunologic cure.
therapeutic_modality: CELL_THERAPY
treatment_term:
preferred_term: hematopoietic stem cell transplantation
term:
id: NCIT:C15431
label: Hematopoietic Cell Transplantation
target_mechanisms:
- target: Biallelic CORO1A Loss-of-Function Variants
description: >-
Replaces CORO1A-deficient haematopoietic cells with donor cells carrying
functional CORO1A.
evidence:
- reference: DOI:10.14785/lymphosign-2019-0004
reference_title: "Successful hematopoietic stem cell transplantation in a patient with a novel mutation in coronin 1A"
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "HSCT using a HLA-matched unrelated donor resulted in long term engraftment and solid immune reconstitution."
explanation: A documented successful transplant with long-term immune reconstitution.
- reference: PMID:25269405
reference_title: "The expanding spectrum of human coronin 1A deficiency."
supports: SUPPORT
directness: INDIRECT
evidence_source: HUMAN_CLINICAL
quote_role: REVIEW_SYNTHESIS
snippet: "complete absence of coronin 1A is associated with severe combined immunodeficiency in humans"
explanation: >-
Review confirming the SCID phenotype that transplantation is intended to
correct; the transplant outcome itself is cited from the case report
above.
- name: Immunoglobulin replacement and anti-infective prophylaxis
description: >-
Supportive care while awaiting or in place of transplant: immunoglobulin
replacement for hypogammaglobulinemia and poor vaccine responses, plus
antibacterial and antiviral prophylaxis. Live vaccines are contraindicated,
given severe post-vaccination varicella.
therapeutic_modality: OTHER
treatment_term:
preferred_term: Supportive Care
term:
id: NCIT:C15747
label: Supportive Care
therapeutic_agent:
- preferred_term: immunoglobulin replacement (IgG)
term:
id: NCIT:C80829
label: Human Immunoglobulin G
target_mechanisms:
- target: Impaired Cell-Mediated Immunity to Viruses and Intracellular Pathogens
description: >-
Prophylaxis and passive antibody reduce the infection burden that follows
from the immune defect; they do not correct it.
evidence:
- reference: PMID:19097825
reference_title: "Severe combined immunodeficiency (SCID) and attention deficit hyperactivity disorder (ADHD) associated with a Coronin-1A mutation and a chromosome 16p11.2 deletion."
supports: SUPPORT
directness: INDIRECT
evidence_source: HUMAN_CLINICAL
snippet: "severe post-vaccination varicella at age 13 months"
explanation: >-
The severe reaction to live varicella vaccine is why live vaccines are
avoided; cited as the basis for the safety caveat rather than for a
prophylaxis trial.
- reference: PMID:42318436
reference_title: "A Novel Variant of CORO1A Gene Contributing to the Development of Primary Immunodeficiency in Children."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "Given the immunological findings, subcutaneous immunoglobulin therapy was initiated at a dosing schedule of every 2 weeks in the daycare unit."
explanation: >-
Immunoglobulin replacement given to a CORO1A-deficient child, the basis
for the immunoglobulin part of this treatment.
discussions:
- discussion_id: coro1a_calcium_flux_mouse_human_mismatch
kind: HUMAN_MODEL_MISMATCH
status: OPEN
prompt: >-
Does defective TCR-induced calcium mobilization explain the T-cell survival
defect in CORO1A-deficient patients, or is that mechanism specific to the
mouse and to null alleles?
attaches_to:
- pathophysiology#Reduced Peripheral T-Cell Survival
rationale: >-
Coro1a-null mice have a profound defect in TCR-induced calcium mobilization
that was proposed to cause their T-cell death. Patients with the C-terminal
p.S401fs allele have the same poor T-cell survival but near-normal calcium
flux, and their F-actin accumulation was proposed instead as the survival
mechanism. The mouse mechanism therefore does not transfer to at least one
human allele, leaving open whether calcium signalling matters in patients
with null alleles, or whether F-actin accumulation is the common route.
evidence:
- reference: PMID:18345003
reference_title: "Regulation of T cell survival through coronin-1-mediated generation of inositol-1,4,5-trisphosphate and calcium mobilization after T cell receptor triggering."
supports: SUPPORT
evidence_source: MODEL_ORGANISM
snippet: "resulted in a profound defect in Ca2+ mobilization, interleukin-2 production, T cell proliferation and T cell survival"
explanation: The murine calcium-dependent survival mechanism.
- reference: PMID:26476480
reference_title: "Recurrent viral infections associated with a homozygous CORO1A mutation that disrupts oligomerization and cytoskeletal association."
supports: SUPPORT
evidence_source: IN_VITRO
snippet: "calcium flux in our patients’ CD4+ and CD8+ T cells after anti-CD3 stimulation was minimally decreased, indicating that calcium flux is not the sole mechanism by which CORO1A regulates T cell survival"
explanation: >-
The human data that contradict the murine calcium mechanism, which is the
substance of this mismatch.
references:
- reference: PMID:18836449
title: "The actin regulator coronin 1A is mutant in a thymic egress-deficient mouse strain and in a patient with severe combined immunodeficiency."
- reference: PMID:19097825
title: "Severe combined immunodeficiency (SCID) and attention deficit hyperactivity disorder (ADHD) associated with a Coronin-1A mutation and a chromosome 16p11.2 deletion."
- reference: PMID:23522482
title: "Whole-exome sequencing identifies Coronin-1A deficiency in 3 siblings with immunodeficiency and EBV-associated B-cell lymphoproliferation."
- reference: PMID:25073507
title: "Compound heterozygous CORO1A mutations in siblings with a mucocutaneous-immunodeficiency syndrome of epidermodysplasia verruciformis-HPV, molluscum contagiosum and granulomatous tuberculoid leprosy."
- reference: PMID:25269405
title: "The expanding spectrum of human coronin 1A deficiency."
- reference: PMID:26476480
title: "Recurrent viral infections associated with a homozygous CORO1A mutation that disrupts oligomerization and cytoskeletal association."
- reference: PMID:16902139
title: "Requirement for coronin 1 in T lymphocyte trafficking and cellular homeostasis."
- reference: PMID:18345003
title: "Regulation of T cell survival through coronin-1-mediated generation of inositol-1,4,5-trisphosphate and calcium mobilization after T cell receptor triggering."
- reference: PMID:24760828
title: "Lytic immune synapse function requires filamentous actin deconstruction by Coronin 1A."
- reference: PMID:18199416
title: "The lupus-related Lmb3 locus contains a disease-suppressing Coronin-1A gene mutation."
- reference: PMID:29942301
title: "Inherited Immunodeficiencies With High Predisposition to Epstein-Barr Virus-Driven Lymphoproliferative Diseases."
- reference: PMID:26424649
title: "Primary Immunodeficiencies Associated with EBV Disease."
- reference: PMID:29225606
title: "Epstein-Barr Virus-Specific Immune Control by Innate Lymphocytes."
- reference: PMID:29946305
title: "Epidermodysplasia Verruciformis: Inborn Errors of Immunity to Human Beta-Papillomaviruses."
- reference: PMID:37915722
title: "Novel hemizygous CORO1A variant leads to combined immunodeficiency with defective platelet calcium signaling and cell mobility."
- reference: PMID:40464874
title: "A rare case of coronin-1A deficiency with IgM dominant membranoproliferative glomerulonephritis."
- reference: PMID:42318436
title: "A Novel Variant of CORO1A Gene Contributing to the Development of Primary Immunodeficiency in Children."
- reference: DOI:10.14785/lymphosign-2019-0001
title: "Coronin 1A deficiency identified by newborn screening for severe combined immunodeficiency"
- reference: DOI:10.14785/lymphosign-2019-0004
title: "Successful hematopoietic stem cell transplantation in a patient with a novel mutation in coronin 1A"
Deep research results are used as seeds for research; they do not undergo the same validation as the main records and may contain errors. How we use deep research.
Create: Severe_Combined_Immunodeficiency_Due_To_CORO1A_Deficiency · 2026-09-28T23:26:27Z · View source
De novo curation of SCID due to CORO1A deficiency (MONDO:0014168, gene CORO1A hgnc:2252) from the required Perplexity deep-research report plus primary PubMed sources. preflight-dr PASS (CORO1A x102 mentions, OMIM 615401 match). The report's suggested HP/GO CURIEs were unusable (22 mislabelled, 2 nonexistent per term_validation), so every ontology term was looked up independently with runoak ols:hp/ols:go/ols:cl and sqlite:obo:hgnc. Rejected report citations: PMID:19027879 (cached by the run but an unrelated epilepsy paper), PMID:34913575 and PMID:25666293 (cached without quotable abstract text). Chain: biallelic CORO1A LoF -> loss of coronin-1A inhibition of Arp2/3 -> F-actin accumulation in lymphocytes -> impaired T-cell migration/thymic egress + reduced peripheral T-cell survival + impaired NK lytic synapse -> profound naive/innate-like T-cell deficiency -> impaired antiviral cell-mediated immunity and failure to control EBV -> EBV-driven B-cell lymphoproliferation; parallel branches for humoral defect, mucocutaneous viral disease, and a 16p11.2 contiguous-gene deletion node for ADHD. A HUMAN_MODEL_MISMATCH discussion records the mouse-vs-human calcium-flux disagreement (PMID:18345003 vs PMID:26476480). No GeneReviews chapter exists (checked offline Bookshelf index + --online PubMed). Validation: validate-disorders PASS; snippets 102/102 verified; disconnected phenotypes 7/30 (5 READOUT-only, neutropenia and short telomeres legitimately isolated). 12 pathophysiology nodes, 30 phenotypes, 19 distinct references (17 PMID + 2 DOI lymphosign).
Severe combined immunodeficiency due to CORO1A deficiency is classified in OMIM under the phenotype “Immunodeficiency 8 with lymphoproliferation (IMD8)” (MIM 615401) and is explicitly linked to biallelic pathogenic variants in CORO1A (MIM 605000) on chromosome 16p11.2.[11][9][9][11] OMIM notes that IMD8 is “an autosomal recessive primary immunodeficiency characterized by early-childhood onset of recurrent infections and lymphoproliferative disorders, often associated with EBV infection.”[11][11] Orphanet catalogs the disorder under ORPHA:228003 as “T‑B+NK+ severe combined immunodeficiency due to CORO1A deficiency,” describing profoundly decreased T‑cell levels, normal B‑cell counts, low immunoglobulin levels, preserved thymic tissue, and clinical manifestations including recurrent infections, EBV‑associated B‑cell lymphoproliferative syndrome/lymphoma, mucocutaneous immunodeficiency, and sometimes neurocognitive impairment and behavioral dysfunction such as ADHD.[40] MedGen and related terminologies group it under “Severe combined immunodeficiency due to CORO1A deficiency,” synonymized with “Immunodeficiency 8; IMMUNODEFICIENCY 8 WITH LYMPHOPROLIFERATION,” and assign MONDO:0014168.[25][25][25]
From a clinical immunology perspective, CORO1A deficiency is often described as a variant of T^−^B^+^NK^+^ SCID, reflecting the typical immunophenotype of markedly reduced naive CD4^+^ and CD8^+^ T cells, normal or slightly reduced B‑cell numbers, and variably reduced NK cells.[8][8][22][2] However, subsequent reports have broadened the spectrum to include patients with combined immunodeficiency (CID) rather than classic SCID, with some residual T‑cell function and later onset of severe infections, and thus the disease is also framed as “Coronin‑1A deficiency–associated CID” in recent reviews.[8][8][2] Primary immunodeficiency organizations such as the Immune Deficiency Foundation present it as “Coronin 1A deficiency,” emphasizing its similarity to SCID in terms of severe T‑cell dysfunction but noting the unusual presence of a structurally intact thymus.[6][6]
In terms of coding identifiers, SNOMED CT includes “Severe combined immunodeficiency due to coronin 1A deficiency” (1229942009), and MedGen cross‑links to ICD‑10‑CM D81.2 (“Combined immunodeficiencies”) and, in some contexts, D84.8 (“Other specified immunodeficiencies”).[25][25] Disease Ontology assigns DOID:0060019 for “coronin‑1A deficiency,” defined as “a severe combined immunodeficiency that is an actin regulator when mutated results in SCID through inhibition of thymic egress of mature thymocytes into peripheral lymphoid organs.”[5] These nosologic descriptors converge on a core concept: a Mendelian, autosomal recessive immunodeficiency due to an actin‑binding protein defect, primarily affecting T‑cell development, egress, and peripheral homeostasis, with characteristic EBV‑driven lymphoproliferative complications.[5][11][8][40][25]
The information synthesized here arises predominantly from aggregated disease‑level resources—OMIM entries, Orphanet summaries, MedGen concept pages, and Disease Ontology records—combined with primary clinical case series and mechanistic studies rather than individual EHR data.[11][8][25][40][25] Landmark clinical papers include the first description of coronin‑1A deficiency as a thymic egress defect in a human SCID patient paralleling a mouse strain (Shiow et al., Nat Immunol 2008, PMID 18836449), the identification of a compound heterozygous truncating CORO1A mutation and a 16p11.2 deletion in SCID with ADHD (Shiow et al., Clin Immunol 2009, PMID 19027879), and subsequent families with hypomorphic missense mutations and unusual mucocutaneous syndromes (Moshous et al., J Allergy Clin Immunol 2013, PMID 23522482; Stray‑Pedersen et al., J Clin Immunol 2014, PMID 25073507).[19][21][27][39][42] Recent reviews compile these cases and provide consensus descriptions of disease characteristics.[8][34][38][38]
Across databases and literature, several synonyms are used:
Orphanet employs “T‑B+NK+ SCID due to CORO1A deficiency,” “T‑B+NK+ SCID due to coronin‑1A deficiency,” and “T‑B+NK+ severe combined immunodeficiency due to coronin‑1A deficiency.”[40] OMIM and MedGen use “Immunodeficiency 8 with lymphoproliferation” and “Severe combined immunodeficiency due to CORO1A deficiency,” while the gene‑based descriptor “Coronin‑1A deficiency” is frequent in immunology literature.[11][25][25][38] Disease Ontology lists “coronin‑1A deficiency” as the primary label for DOID:0060019.[5] Some case reports refer to “Coronin‑1A‑deficient SCID,” “late/hypomorphic‑like SCID due to CORO1A,” or “mucocutaneous‑immunodeficiency syndrome of EV–HPV associated with CORO1A deficiency,” highlighting specific clinical features.[22][42] In EBV‑focused reviews, the entity is subsumed under “primary immunodeficiencies associated with EBV disease,” with coronin actin binding protein 1A listed among proteins whose deficiency predisposes to EBV‑associated B‑cell lymphoma and lymphoproliferation.[12][14][34][34]
For ontology mapping, the most appropriate MONDO term is MONDO:0014168 “severe combined immunodeficiency due to CORO1A deficiency,” with logical axioms connecting to OMIM 615401, Orphanet ORPHA:228003, DOID:0060019, and SNOMED CT 1229942009.[25][25][40][25] This integrated perspective facilitates consistent cross‑referencing across knowledge bases.
The primary etiologic factor in this disease is biallelic germline mutation in CORO1A, an autosomal recessive inheritance pattern confirmed by multiple kindreds.[11][9][27][39][42] OMIM emphasizes that immunodeficiency‑8 with lymphoproliferation is “caused by homozygous or compound heterozygous mutation in the CORO1A gene on chromosome 16p11.”[11][11] All reported affected individuals have inherited one pathogenic or hypomorphic CORO1A allele from each parent; heterozygous carriers are clinically unaffected, supporting a recessive loss‑of‑function mechanism.[4][8][27]
The CORO1A gene encodes coronin‑1A, also known as p57, coronin 1, or coronin actin‑binding protein 1A, a member of the coronin family of actin‑associated proteins predominantly expressed in hematopoietic cells.[9][9][8][36] In humans, CORO1A resides at 16p11.2 with genomic coordinates 16:30,183,602–30,189,076 (GRCh38).[9][9][9] Coronin‑1A localizes to the plasma membrane and F‑actin–rich regions, including the leading edge of migrating lymphocytes and immunological synapses, and is implicated in regulation of actin filament branching via Arp2/3, T‑cell motility, thymic egress, survival signaling, and formation of effective immune synapses.[19][21][35][36][37]
Clinical variant types include frameshift truncating mutations, splice‑site mutations, large exon deletions, and hypomorphic missense variants. Stray‑Pedersen et al. identified compound heterozygous frameshift variants c.248_249delCT (p.P83RfsX10) and c.1077delC (p.Q360RfsX44) in two siblings presenting with late‑onset mucocutaneous immunodeficiency syndrome and EV‑HPV infection, resulting in complete loss of coronin‑1A protein expression.[22][42] Moshous et al. reported three siblings with a homozygous missense mutation c.717C>A (p.V134M) in the β‑propeller domain, which “abrogates almost completely the protein expression in the patients’ cells” and causes hypomorphic coronin‑1A deficiency.[39][42] Shiow et al. described a girl with SCID and ADHD who was compound heterozygous for a truncating CORO1A mutation and a de novo 600‑kb 16p11.2 deletion encompassing CORO1A.[27][9][8] More recent work has identified a hemizygous c.19C>T (p.Arg7Cys) variant associated with combined immunodeficiency, decreased cellular coronin‑1A protein levels with normal mRNA, impaired NK‑cell cytotoxicity, platelet calcium signaling, and defects in motility of granulocytes and mesenchymal stromal cells.[2][1] ClinVar catalogues large multi‑exon deletions of CORO1A as pathogenic variants underlying SCID phenotypes.[28]
Collectively, these mutations predominantly result in reduced or absent coronin‑1A protein expression and thus are functional loss‑of‑function alleles. Experimental evidence from patient lymphocytes and murine Coro1a‑null lines shows impaired T‑cell migration, survival, and signaling, bolstering the causal link between CORO1A loss and immunodeficiency.[19][8][35][10][39] The disease therefore fits squarely within the Mendelian category of monogenic primary immunodeficiencies with a defined causal gene.
Environmental or lifestyle factors are not primary causes of CORO1A deficiency; rather, they modulate clinical expression and complications in affected individuals. There is no evidence that toxins, diet, or occupational exposures increase the risk of developing the genetic defect, as the condition arises from inherited mutations present from conception.[11][8][40] However, infectious exposures play a pivotal role in triggering disease manifestations, particularly EBV and human papillomaviruses (HPV) of the beta‑HPV group.
EBV infection is nearly ubiquitous globally, but in individuals with coronin‑1A deficiency, impaired cytotoxic T‑cell and NK‑cell control of EBV leads to persistent viremia and a spectrum of EBV‑associated lymphoproliferative diseases, ranging from chronic active EBV infection to B‑cell lymphomas.[12][14][34][39][34] Reviews of EBV‑associated primary immunodeficiencies list coronin‑1A deficiency as a recognized cause of EBV‑driven B‑cell lymphoma and lymphoproliferative disease, often in early childhood.[12][14][34][34] Moshous et al. explicitly note “a primary immunodeficiency with increased susceptibility to EBV-induced lymphoproliferation…associated with hypomorphic Coronin‑1A mutation.”[39]
Similarly, HPV infections, typically asymptomatic in immunocompetent individuals, can produce chronic, disseminated plane warts and pityriasis versicolor–like lesions characteristic of epidermodysplasia verruciformis in CORO1A‑deficient patients. Stray‑Pedersen et al. reported siblings with disseminated EV‑like HPV infection (HPV‑5 and 17 by PCR), molluscum contagiosum, oral‑cutaneous HSV‑1 ulcers, and granulomatous tuberculoid leprosy in the context of CORO1A deficiency.[18][22][23][42] Recent dermatologic series regard CORO1A mutations as one of the inborn errors of immunity underlying inherited EV, alongside MST1, RHOH, and TMC6/TMC8 mutations.[15][18][20][24]
Thus, while the etiologic lesion is genetic, common viral infections serve as environmental triggers that reveal and amplify the immunodeficiency, resulting in opportunistic infections and oncogenesis. It is important to distinguish these triggers from causative factors: EBV and HPV are necessary for certain manifestations (lymphoma, EV), but they do not cause the underlying disease state; rather, they exploit the defective immune system created by CORO1A mutations.[12][14][18][34][39][34]
Given the rarity of CORO1A deficiency and its monogenic nature, genetic risk is driven almost entirely by carrier status in parents and consanguinity in affected families. Many reported kindreds arise in consanguineous contexts, such as Moroccan siblings with homozygous V134M mutation described by Moshous et al., reflecting increased probability of homozygous recessive alleles in consanguineous pedigrees.[39][42] There is no evidence of polygenic susceptibility loci or modifier alleles altering penetrance, although phenotypic variability among patients suggests potential genetic modifiers that remain unidentified.[8][2][38][42]
Environmental “risk factors” in the conventional epidemiologic sense—smoking, diet, occupational exposures—have not been systematically linked to disease severity due to the small number of cases. However, early and repeated exposure to EBV, high community prevalence of oncogenic EBV strains, and inadequate infection control may increase the likelihood and severity of EBV‑associated complications in affected children, as inferred from families in high EBV endemic settings.[12][14][34][39][34] Conversely, rigorous prophylactic antibiotic and antiviral strategies, reduction of environmental pathogen exposure, and early hematopoietic stem cell transplantation (HSCT) represent protective factors that can modify disease course by limiting infections and restoring immune function, though they do not alter the underlying genotype.[8][8][26][26]
No specific genetic protective variants have been described that ameliorate CORO1A deficiency. In mouse models, complete Coro1a knockout produces profound T‑cell deficiency without apparent compensation by other coronin family members, suggesting limited redundancy.[35][10] However, the unique case of SCID with 16p11.2 deletion (encompassing 24 genes) illustrates that comorbid copy number variation can modify the phenotype, contributing neurodevelopmental disorders such as ADHD and altering the overall clinical picture.[27][9][32][8] This is an example of a genetic co‑factor worsening rather than protecting the disease state.
Gene–environment interactions are evident in the way CORO1A mutations modulate lymphocyte responses to pathogens. Coronin‑1A deficiency disrupts actin dynamics required for proper immune synapse formation and cytotoxic function, so environmental exposure to viruses that rely heavily on T‑cell and NK‑cell control—EBV, HPV, HSV, mycobacteria—elicits particularly severe disease manifestations.[12][14][18][35][39][42] In vitro studies in coronin‑1A‑deficient macrophages and lymphocytes demonstrate altered phagosome maturation and calcium signaling, which may interact with microbial virulence strategies.[35][36] Nonetheless, current data do not support traditional variable penetrance based on environmental exposures; rather, they highlight ubiquitous pathogens as triggers of manifestations in a genetically determined immunodeficiency.
Patients with CORO1A deficiency manifest a spectrum of clinical phenotypes that, taken together, define a distinctive primary immunodeficiency with both infectious susceptibility and immune dysregulation. Reviews summarizing all known cases emphasize several recurring themes: recurrent upper respiratory tract infections in infancy and childhood; severe or opportunistic viral infections, notably EBV‑associated lymphoproliferation and B‑cell lymphoma; mucocutaneous infections including EV‑like HPV disease, molluscum contagiosum, HSV‑1 ulcers, and sometimes mycobacterial infections such as tuberculoid leprosy; lymphopenia with profoundly reduced naive CD4^+^ T cells; variably low B and NK cells; hypogammaglobulinemia or non‑protective vaccine responses; and, in some cases, neurocognitive impairment or ADHD.[8][22][34][6][39][42]
The age of onset is typically in infancy or early childhood, consistent with Orphanet’s notation of neonatal, infancy, or childhood onset.[40] The classical SCID phenotype appears within the first months of life, with severe recurrent infections, failure to thrive, and profound T‑cell deficiency detected by newborn screening using T‑cell receptor excision circle (TREC) assays.[7][29][29] On the other end of the spectrum, hypomorphic or compound heterozygous mutations can produce later onset combined immunodeficiency, with mucocutaneous syndromes appearing around school age or later, as in the siblings with EV‑HPV whose disease debuted around age seven.[22][42] In the Moshous kindred, EBV‑associated lymphoproliferative disease may present in early childhood but could be preceded by recurrent ENT and respiratory infections.[39][14]
Symptom severity is generally high, with life‑threatening complications such as EBV‑positive lymphoma, fatal lymphoproliferative syndrome, severe pneumonia, bronchiectasis, and disseminated cutaneous HPV lesions.[18][8][34][39][42] However, the progression is variable: some patients experience rapidly progressive disease requiring urgent HSCT, while others exhibit more chronic, relapsing‑remitting courses of infections and lymphoproliferation, influenced by residual T‑cell function and access to treatment.[8][8][26][26] Quality of life is profoundly affected by frequent hospitalizations, invasive interventions, chronic infections, disfiguring skin lesions, and neurocognitive issues, although formal QOL studies are lacking due to the small numbers; case reports nonetheless describe significant functional impairments and psychosocial burden, particularly in patients with ADHD or neurodevelopmental delay.[27][6][40]
Below, major phenotype domains are discussed with suggested HPO terms and characteristics.
The cardinal immunologic abnormality is T‑cell lymphopenia, particularly of naive CD4^+^ T cells. All coronin‑1A–deficient patients described to date have shown a T(−/low), B(low/+), NK(low/+) phenotype, with markedly reduced naive peripheral T cells and near‑undetectable TRECs on newborn screening where measured.[7][8][22][29][29] Stray‑Pedersen’s siblings demonstrated “absent CD4CD45RA(+) (naïve) T and memory B cells, low NK cells and abnormally increased double‑negative (DN) γδ T‑cells.”[22][42] Moshous et al. similarly reported “significant diminution of naive T-cell numbers, impaired development of a diverse T-cell repertoire, near-to-absent invariant natural killer T cells, and severely diminished mucosal-associated invariant T cell numbers.”[39] Thus, suggested HPO terms include HP:0008069 (T‑cell lymphopenia), HP:0005308 (CD4+ T‑cell lymphopenia), HP:0031494 (Naive CD4+ T‑cell deficiency), HP:0031520 (Naive T‑cell deficiency), HP:0005348 (NK‑cell lymphopenia), and HP:0002721 (Abnormal B‑cell count).
Functionally, lymphocyte proliferative responses to mitogens are impaired but not completely absent, reflecting residual signaling capacity in some patients.[8][34] Serum immunoglobulins are detectable, but specific antibody titers following vaccines are low or absent, except occasionally against tetanus toxoid.[8][34] HPO mapping would include HP:0002715 (Abnormal immunoglobulin level), HP:0004430 (Impaired antibody response to vaccination), and HP:0002729 (Abnormal lymphocyte proliferation). Combined immunodeficiency manifests clinically as recurrent infections, opportunistic pathogens, and poor clearance of viruses, aligning with HP:0002718 (Recurrent infections) and HP:0002725 (Immunodeficiency).
Quality of life impact stems from frequent infections, need for long‑term antibiotic prophylaxis and IVIG, and risk of lymphoma, necessitating intensive medical care and limiting normal childhood activities. Although formal EQ‑5D or SF‑36 data are absent, anecdotal descriptions of hospitalizations, HSCT, and chronic skin disease suggest significant impairment in mobility, self‑care, usual activities, pain/discomfort, and anxiety/depression domains.
Recurrent upper respiratory tract infections, otitis media, and pneumonia are common early manifestations, consistent across case series.[8][8][34][6] For example, coronin‑1A‑deficient patients in Puck and colleagues’ review “all suffered from upper respiratory tract infections; and inability to control EBV was a prominent feature, associated with fatal lymphoproliferative syndrome and lymphoma at a particularly young age.”[8][8] Suggested HPO terms include HP:0002205 (Recurrent upper respiratory tract infections), HP:0002090 (Pneumonia), and HP:0000388 (Recurrent otitis media).
EBV‑associated disease is particularly prominent. Moshous et al. described three siblings in whom “one patient had an EBV-positive lymphoproliferative process and two had EBV lymphomas,” identifying CORO1A mutation as the underlying defect.[14][39] Reviews of EBV in primary immunodeficiency note that at least five coronin‑1A‑deficient patients have developed EBV‑driven B‑cell lymphoma.[34][34] Phenotypically, this corresponds to HP:0002746 (Lymphoma), HP:0002733 (Lymphoproliferative disorder), HP:0008408 (Epstein–Barr virus infection), and HP:0100085 (Chronic active EBV infection).
Mucocutaneous infections are a distinguishing feature in hypomorphic and compound heterozygous cases. Stray‑Pedersen et al. reported siblings with a “mucocutaneous-immunodeficiency syndrome of epidermodysplasia verruciformis-human-papilloma-virus (EV-HPV), molluscum contagiosum and oral-cutaneous herpetic (HSV-1) ulcers; the older female sibling also had a disfiguring granulomatous tuberculoid leprosy.”[22][42] EV‑like HPV disease presents as disseminated flat warts and pityriasis versicolor–like lesions associated with beta‑HPV infection and increased risk of non‑melanoma skin cancer.[18][23][24] Appropriate HPO terms include HP:0000998 (Epidermodysplasia verruciformis), HP:0009740 (Molluscum contagiosum), HP:0001657 (Recurrent herpes simplex infections), HP:0002728 (Opportunistic infections), and HP:0002826 (Leprosy). Bronchiectasis has been reported, reflecting chronic pulmonary damage from recurrent infections (HP:0002110).[18][23][42]
The progression of infectious phenotypes is often chronic and cumulative: repeated respiratory infections can lead to structural lung damage, acute EBV infection can transition to chronic active EBV and lymphoma, and persistent HPV infection can evolve into EV and, later, non‑melanoma skin cancer.[12][18][23][24][34][39] These complications significantly impair quality of life via respiratory insufficiency, skin pain and pruritus, cosmetic disfigurement, cancer risk, and the psychological burden of chronic illness.
Beyond lymphopenia, coronin‑1A‑deficient patients exhibit a tendency toward EBV‑driven B‑cell lymphomas and lymphoproliferative syndromes. The Moshous siblings exemplify this, with documented EBV‑positive lymphomas.[14][39] Reviews of EBV‑associated primary immunodeficiencies list coronin‑1A deficiency among syndromes predisposing to EBV‑associated B‑cell lymphomas and lymphoproliferative disease.[12][14][34][34] HPO terms include HP:0002746 (Lymphoma), HP:0002733 (Lymphoproliferative disorder), and HP:0004370 (B‑cell lymphoma).
An interesting hematologic feature in some cases is neutropenia. A newborn diagnosed by TREC‑based screening had profound T‑cell deficiency accompanied by neutropenia, an unusual finding for this condition and highlighted as a novel phenotype.[7][29] HPO mapping would include HP:0001875 (Neutropenia). Another reported case displayed IgM‑dominant immunoglobulin profile with hypogammaglobulinemia, suggestive of impaired class‑switch recombination or memory B‑cell defects.[38][38] This aligns with HP:0002715 (Abnormal immunoglobulin level), HP:0002729 (Abnormal lymphocyte proliferation), and HP:0002758 (Recurrent bacterial infections).
From a progression standpoint, oncologic phenotypes such as lymphoma significantly worsen prognosis and require aggressive treatment (chemotherapy, HSCT), further affecting quality of life and survival.[34][39][34] The psychological impact of cancer diagnoses in young children and adolescents, layered on chronic immunodeficiency, is considerable but under‑documented.
Dermatologic manifestations are central in CORO1A‑related EV and mucocutaneous immunodeficiency syndromes. Epidermodysplasia verruciformis (EV) is described as “a rare skin disease characterized by persistent disseminated flat warts and pityriasis versicolor-like lesions, associated with a high risk of non-melanoma skin cancer (NMSC).”[18][24] In the CORO1A siblings, lesions were HPV‑5 and HPV‑17 positive by PCR, indicating beta‑HPV infection.[18][22][23][42] HPO terms include HP:0000998 (Epidermodysplasia verruciformis), HP:0001581 (Flat wart), HP:0001014 (Pityriasis versicolor), and HP:0002762 (Non‑melanoma skin cancer).
Molluscum contagiosum and chronic oral‑cutaneous HSV‑1 ulcers add to the dermatologic burden, causing pain, pruritus, and cosmetic disfigurement, especially on exposed areas such as the face and extremities.[22][23][42] Tuberculoid leprosy in one sibling produced disfiguring granulomatous lesions.[22][42] Over time, these lesions can progress, fluctuate, or respond only partially to therapy, resulting in chronic dermatologic disability, psychological distress due to appearance changes, and social stigmatization.
Quality of life impacts are severe in EV, as noted in dermatology literature where patients often face stigma and functional limitations due to extensive lesions.[18][23][24] While formal QOL metrics (e.g., Dermatology Life Quality Index) have not been applied specifically to CORO1A‑related EV, extrapolation from EV cohorts suggests significant impairment across physical, emotional, and social domains.
Neurological and behavioral phenotypes in coronin‑1A deficiency are less consistent but noteworthy in specific contexts. Orphanet notes that “some patients may show developmental delay, neurocognitive impairment, and behavioral dysfunction (in particular attention deficit-hyperactivity disorder).”[40] The clearest example is the SCID patient described by Shiow et al., who had attention deficit hyperactivity disorder (ADHD) due to a de novo 16p11.2 microdeletion encompassing CORO1A and 24 other genes, a region recurrently associated with autism spectrum disorders and ADHD.[27][9][32][8] The authors conclude that “deletion as well as duplication of this same interval on 16p11.2 is well recognized and has been associated with autism spectrum disorder and neurodevelopmental disorders including ADHD…our patient’s 16p11.2 deletion also predisposed her to ADHD.”[27][9][8]
It remains uncertain whether pure CORO1A loss (without broader 16p11.2 CNV) contributes directly to neurobehavioral phenotypes, although coronin‑1A is expressed in the nervous system and involved in nerve growth factor signaling pathways in mice.[35][10][37] Mouse studies show that adult Coro1a knockout animals have no significant gross neuroanatomical abnormalities, but functional behavioral assessments are limited.[10] Therefore, suggested HPO terms in human cases include HP:0001263 (Global developmental delay), HP:0007018 (Attention deficit hyperactivity disorder), HP:0000737 (Autism), and HP:0001250 (Seizures) where applicable, but these should be annotated with caution and linked to co‑occurring genomic alterations when present.
Quality of life consequences of ADHD and developmental delay are substantial, affecting schooling, social integration, and family dynamics, as described in general neurodevelopmental literature. In CORO1A deficiency, these impairments compound the burden of immunodeficiency and chronic illness, necessitating multidisciplinary care.
The causal gene CORO1A (HGNC:2252) encodes coronin‑1A, also known as coronin, actin binding protein 1A, CLABP, p57, Lmb3, and coronin 1.[9][10][9][10] NCBI Gene assigns gene ID 11151 in humans; the mouse ortholog Coro1a has gene ID 12721.[10][10][37] Cytogenetically, CORO1A is located at 16p11.2, a region subject to recurrent copy number variations associated with neurodevelopmental disorders.[9][27][9][32][8] OMIM summarizes coronin‑1A as “an actin-regulating protein that is expressed mainly in hematopoietic cells,” highlighting its role in immune cell biology.[9][9]
Gene Ontology (GO) annotations for coronin‑1A include molecular functions such as “actin filament binding activity” and “identical protein binding activity,” biological processes such as “regulation of actin filament polymerization,” “cellular response to interleukin‑4,” “nerve growth factor signaling pathway,” and “positive regulation of T‑cell proliferation,” and cellular components including “cell leading edge,” “early endosome,” “immunological synapse,” and “plasma membrane.”[37] These GO terms capture the protein’s positioning at the interface of actin cytoskeleton regulation, signal transduction, and immune synapse formation, consistent with functional studies demonstrating impaired T‑cell motility and immune synapse assembly in coronin‑1A deficiency.[19][21][35][36][39]
Reported pathogenic CORO1A variants include:
Frameshift truncations such as c.248_249delCT (p.P83RfsX10) and c.1077delC (p.Q360RfsX44), which create premature stop codons leading to nonsense‑mediated decay and complete loss of protein expression.[22][42] These variants fulfill ACMG criteria for pathogenicity as null alleles in a gene where loss of function is a known disease mechanism (PVS1), segregating in affected siblings (PP1), and absent or extremely rare in population databases (PM2).[22][42][28]
Missense variants such as c.717C>A (p.V134M) in the β‑propeller domain, which severely reduce protein expression and function. Moshous et al. demonstrated abrogated coronin‑1A expression in patient cells, providing strong functional evidence (PS3) and evolutionary conservation of the affected residue (PP3), supporting classification as pathogenic or likely pathogenic.[39][42]
Hemizygous missense c.19C>T (p.Arg7Cys) variants, which decrease coronin‑1A protein levels but leave mRNA intact, cause combined immunodeficiency with impaired NK cytotoxicity and platelet calcium signaling.[2][1] Functional assays showing reduced protein and cellular defects support pathogenicity (PS3), though full ACMG classification may be “likely pathogenic” pending segregation and population frequency data.[2][31]
Gross deletions encompassing exons 1–10 of CORO1A, including the initiator codon, are classified as pathogenic in ClinVar, as they are predicted to result in absent protein and have been observed in individuals with SCID whose genotype is consistent with trans configuration of another pathogenic variant.[28][9] Such multi‑exon deletions also often extend beyond CORO1A to neighboring genes within the 16p11.2 interval, complicating phenotypic interpretation.[27][9][8]
ClinVar entries include variants like NM_007074.4(CORO1A):c.885T>C (p.Phe295=), classified as likely benign for severe combined immunodeficiency due to CORO1A deficiency, illustrating that synonymous variants without functional impact should not be over‑interpreted.[33][31] This underscores the need for careful ACMG evaluation integrating functional studies.
Allele frequencies of pathogenic CORO1A variants in gnomAD and other population databases are extremely low or absent, consistent with the rarity of the disease and strong purifying selection against complete coronin‑1A deficiency.[38][38] Hypomorphic alleles may exist at slightly higher frequencies in certain populations but are not common. No somatic CORO1A mutations have been linked to cancer or other diseases in COSMIC or TCGA to date; coronin‑1A dysfunction appears predominantly germline and immunologic.[31][33]
The functional consequences of these variants are uniformly loss‑of‑function at the protein level, whether by truncation, nonsense‑mediated decay, protein misfolding and degradation, or impaired translation. There is no evidence of gain‑of‑function or dominant negative effects; heterozygotes are clinically unaffected and mice with one functional Coro1a allele display normal T‑cell counts.[4][8][10] This fits a recessive null model where coronin‑1A activity is reduced below a critical threshold only when both alleles are affected.
To date, no specific modifier genes have been systematically demonstrated to alter severity or expression of CORO1A deficiency. However, the co‑occurrence of 16p11.2 microdeletions, which encompass multiple genes including CORO1A, raises the possibility that other genes in the interval, such as those implicated in neurodevelopmental disorders, modify neurobehavioral phenotypes or broader systemic features.[27][9][32][8] For example, genes within 16p11.2 have been linked to autism spectrum disorders and language delay, and their deletion in combination with CORO1A truncation may account for ADHD and developmental issues in the SCID patient described by Shiow et al.[27][9][8]
Epigenetic changes specifically associated with CORO1A deficiency have not been reported. Given coronin‑1A’s role in actin dynamics and signal transduction at immune synapses, it is conceivable that downstream transcriptional programs are altered in T cells lacking coronin‑1A, potentially affecting chromatin states and epigenetic marks at immune genes. However, no dedicated epigenomics or DNA methylation studies in CORO1A‑deficient lymphocytes have been published to date. The absence of data should be explicitly noted in ontology records.
Besides single‑gene mutations, large copy number variations involving 16p11.2 have been documented in coronin‑1A deficiency. Shiow et al. identified a de novo 600‑kb interstitial deletion of chromosome 16p11.2 in a girl with SCID and ADHD, encompassing 25 genes including CORO1A; on the other allele, she carried a 2‑bp deletion in CORO1A, resulting in compound heterozygosity and complete coronin‑1A loss.[27][9][8] Genome‑wide oligonucleotide array analysis demonstrated hemizygosity across the 16p11.2 region, confirming the CNV and linking it to both immunodeficiency and neurodevelopmental phenotypes.[27][9][32][8]
ClinVar notes similar multi‑exon deletions of CORO1A that may extend beyond the gene’s coding region, potentially affecting neighboring genes and complicating genotype–phenotype correlations.[28] Rarechromo and other CNV resources indicate that loss or gain of material from 16p11.2 is among the most common structural chromosome disorders, associated with autism, ADHD, and language or psychiatric conditions.[32] Thus, in some patients, coronin‑1A deficiency exists within a broader CNV syndrome, necessitating careful clinical and molecular interpretation.
Ontology entries should capture that chromosomal microdeletions of 16p11.2 (e.g., dbVar nsv####, DECIPHER records) can cause CORO1A deficiency when combined with another CORO1A allele mutation, and that such CNVs may introduce additional phenotypes beyond immunodeficiency.
As a monogenic, autosomal recessive disease, CORO1A deficiency arises independent of classical environmental exposures. There is no evidence that toxins, radiation, pollution, or other non‑infectious environmental factors directly induce CORO1A mutations or significantly alter penetrance. Most patients come from varied geographic and socioeconomic backgrounds, and no clustering around specific environmental exposures has been reported.[11][8][40]
However, the immunodeficiency renders patients highly susceptible to environmental pathogens, particularly respiratory viruses and bacteria, herpesviruses, and HPV. In resource‑limited settings or environments with high pathogen burden, the frequency and severity of infections may be greater, leading to earlier and more severe clinical manifestations than in settings with robust infection control measures.[18][8][34][39] For ontology purposes, environmental factors should be annotated as modulators of clinical course rather than etiologic agents.
Lifestyle factors such as smoking, diet, exercise, or alcohol consumption have not been systematically studied in this tiny patient population. Nonetheless, general immunology principles suggest that smoking or malnutrition could further impair respiratory defenses and immune function, worsening infection outcomes, although these would be generic and not disease‑specific risk factors. Given the lack of direct data, such relationships should be flagged as inferred rather than demonstrated.
EBV (Human herpesvirus 4; NCBI Taxon ID 10376) is a central infectious agent interacting with CORO1A deficiency. In healthy individuals, EBV infection is typically controlled by cytotoxic CD8^+^ T cells and NK cells; in coronin‑1A deficiency, impaired cytoskeletal rearrangements at immune synapses, defective calcium signaling, and T‑cell lymphopenia compromise immune control, resulting in chronic EBV viremia and lymphoproliferative diseases.[12][14][34][39][34] EBV‑associated pathologies include chronic active EBV, fulminant hemophagocytic lymphohistiocytosis (HLH), infectious mononucleosis, and B‑cell lymphomas.[12][14][34][34] Coronin‑1A deficiency is specifically linked to EBV‑associated non‑Hodgkin lymphomas and lymphoproliferative syndromes.[12][14][34][39][34]
HPV, particularly beta‑HPV types such as HPV‑5 and HPV‑17 (NCBI Taxon ID group 333752), causes EV‑like cutaneous lesions in CORO1A‑deficient patients. These manifestations depend on chronic infection with beta‑HPVs, which are otherwise asymptomatic in immunocompetent hosts.[18][23][24][42] The presence of disseminated EV‑like lesions and increased risk of non‑melanoma skin cancer underscores the interplay between CORO1A‑mediated T‑cell immunity and viral oncogenesis.[18][23][24]
Other infectious agents include HSV‑1 (Human herpesvirus 1; NCBI Taxon ID 10298), causing chronic oral‑cutaneous ulcers; Mycobacterium leprae (Taxon ID 1769), leading to tuberculoid leprosy in one sibling; and various respiratory bacteria and viruses contributing to bronchiectasis.[18][22][23][34][42] These pathogens exploit the impaired T‑cell responses in coronin‑1A deficiency, but they are not etiologic for the genetic disease itself.
For ontology mapping, EBV and HPV should be linked as environmental triggers or co‑morbid infections (CHEBI:5522 for viral entities, IEDB epitope records for EBV antigens), with annotation that their pathologies are significantly amplified in CORO1A deficiency.
Biallelic loss‑of‑function or hypomorphic mutations in CORO1A lead to reduced or absent coronin‑1A protein expression in hematopoietic cells, particularly T lymphocytes.[11][8][22][39]
Reduced coronin‑1A protein leads to impaired regulation of Arp2/3‑mediated actin branching and defective localization of coronin‑1A to the leading edge and immunological synapses of T cells, resulting in abnormal actin dynamics.[19][21][35][36]
Defective actin dynamics and coronin‑1A mislocalization lead to impaired T‑cell motility within thymus and lymph nodes, causing a block in thymic egress of mature thymocytes into the circulation and peripheral lymphoid organs.[19][21][35][10]
Blocked thymic egress leads to profound peripheral T‑cell lymphopenia, particularly of naive CD4^+^ and CD8^+^ T cells, with near‑absent TRECs and altered TCR repertoire diversity, while thymic tissue remains structurally present.[7][19][8][22][29][39]
In parallel, coronin‑1A deficiency leads to impaired immune synapse formation, defective TCR signaling, abnormal calcium flux, and increased F‑actin accumulation at synapses, resulting in increased T‑cell apoptosis and reduced survival of peripheral T cells.[34][35][39]
Combined deficits in T‑cell egress, motility, and survival lead to a T(−/low), B(low/+), NK(low/+) immunophenotype with profoundly reduced naive T cells, impaired T‑cell proliferation to mitogens, reduced invariant NKT and MAIT cells, and variably low memory B and NK cells.[8][22][35][39][42]
This severe T‑cell dysfunction leads to impaired cell‑mediated immune responses against viruses and intracellular pathogens, resulting in recurrent infections, chronic viral persistence (especially EBV and HPV), and opportunistic infections such as HSV‑1 and mycobacteria.[12][14][18][8][34][39][42]
Chronic EBV infection in the setting of impaired cytotoxic T‑cell and NK‑cell control leads to EBV‑driven B‑cell lymphoproliferation and lymphoma, with loss of NKT cells and altered cytoskeletal rearrangement at immune synapses further predisposing to EBV‑associated malignancies.[12][14][16][34][39][34]
Chronic beta‑HPV infection in skin in the setting of defective T‑cell surveillance leads to EV‑like cutaneous lesions, persistent EV‑HPV infection, and increased risk of non‑melanoma skin cancer.[18][22][23][24][42]
Recurrent respiratory infections and chronic inflammation lead to secondary tissue damage such as bronchiectasis, while systemic immune dysregulation contributes to elevated IgE, hypogammaglobulinemia, and shortened telomeres in some patients.[18][22][38][42]
The cumulative effect of severe immunodeficiency, opportunistic infections, and lymphoproliferative malignancies leads to high morbidity and mortality in early childhood unless corrected by HSCT, which restores donor T‑cell function and resolves immunologic defects.[8][8][26][26]
Where explicit mechanisms have not been experimentally demonstrated in human cells (e.g., telomere shortening), they are inferred from observations of shortened telomeres and generalized immune stress rather than direct mechanistic assays.[22][42]
At the molecular level, coronin‑1A participates in actin cytoskeleton regulation through interactions with Arp2/3 complex and F‑actin. Shiow et al. showed that a point substitution in coronin‑1A (lysine for glutamic acid at position 26 in the mouse Ptcd strain) enhanced coronin‑1A’s inhibition of Arp2/3, mislocalized the protein from the leading edge of migrating T cells, and resulted in irregularly shaped protrusions and intrinsic migration defects.[19][21] Two‑photon microscopy revealed that Coro1A‑deficient T cells had abnormal motility within lymph nodes, establishing coronin‑1A as a regulator of T‑cell egress and trafficking in response to sphingosine‑1‑phosphate (S1P) signaling.[19][21]
Gene Ontology processes relevant here include GO:0030036 (actin cytoskeleton organization), GO:0030833 (regulation of actin filament polymerization), GO:0007015 (actin filament organization), and GO:0051270 (regulation of T‑cell migration).[37] Coronin‑1A’s role in S1P‑dependent thymic egress is linked to pathways involving S1P receptor 1 (S1P1) and downstream Rho GTPases that coordinate actin rearrangement.[19][21] mDia1, a formin family actin nucleator promoting unbranched actin filaments, is also required for thymic egress, highlighting the balance between Arp2/3‑mediated branching and formin‑mediated elongation.[19][21]
Cellular processes affected include T‑cell migration (GO:0072678), T‑cell survival (GO:0042089), immune synapse formation (GO:0001772), TCR signaling (GO:0050852), and calcium‑dependent signaling (GO:0007165). Föger et al. and subsequent reviews report that coronin‑1A deficiency impacts “development, survival, TCR signaling, immune synapse formation and migration” across lymphocyte lineages.[34][8] Impaired calcium flux and F‑actin accumulation at the immune synapse result in increased T‑cell apoptosis and CD4^+^ lymphopenia, as documented in coronin‑1A–deficient human patients.[34][8]
Coronin‑1A also interacts with pathways in macrophages. Early work suggested coronin‑1A recruited to mycobacterial phagosomes prevented their transfer to lysosomes, aiding Mycobacterium tuberculosis survival; coronin‑1A deficiency in mice led to enhanced lysosomal delivery and mycobacterial killing.[35] However, later studies indicate that coronin‑1A‑deficient macrophages retain intact motility and phagocytosis, suggesting that T cells are more critically dependent on coronin‑1A than macrophages in vivo.[35][36]
Coronin‑1A is a WD40‑repeat protein forming a β‑propeller structure that binds actin and other partners at the plasma membrane and immunological synapses.[36][39] Missense mutations such as V134M likely alter this β‑propeller’s stability, leading to protein misfolding and degradation, as evidenced by abrogated coronin‑1A expression in patient cells.[39] Frameshift and large deletions result in truncated, nonfunctional proteins or complete loss of translation, extinguishing coronin‑1A activity.[22][28][42]
Biochemically, coronin‑1A deficiency leads to abnormal F‑actin dynamics at the immune synapse, with excessive accumulation and impaired turnover, which in turn disrupts assembly of signaling complexes and the spatial organization of TCR, co‑receptors, and adhesion molecules.[34][35][36] Calcium signaling defects have been documented in coronin‑1A‑deficient T cells and platelets, reflecting impaired coupling between receptor engagement and calcium influx.[2][34] These abnormalities compromise activation thresholds, cytokine production, and effector functions.
Coronin‑1A’s role in S1P1 signaling suggests that its absence may alter downstream signaling cascades including RhoA, Rac1, and Cdc42 pathways, though detailed biochemical mapping in human T cells is incomplete. Nonetheless, the net effect is a failure of T cells to properly respond to chemotactic gradients, exit thymus and lymph nodes, and home to sites of infection.
Coronin‑1A deficiency primarily affects T cells (CL:0000084), including naive CD4^+^ T cells (CL:0000895), naive CD8^+^ T cells (CL:0000900), invariant NKT cells (CL:0000815), and MAIT cells (CL:0001054).[35][39][42] NK cells (CL:0000623) and B cells (CL:0000236) are variably affected, with reduced NK counts and memory B cells in some patients.[8][22][39][42] Macrophages (CL:0000235) and dendritic cells (CL:0000451) appear less directly impacted, though coronin‑1A is expressed and functional in these cells as well.[35][36][37]
The immune consequences include reduced thymic egress, peripheral T‑cell depletion, impaired effector functions, and failure to control chronic viral infections. Tissue damage arises indirectly from infections and chronic inflammation: recurrent pneumonia leads to bronchiectasis (UBERON:0000397 for lung, HP:0002110 for bronchiectasis), chronic EV lesions increase risk of cutaneous squamous cell carcinoma and basal cell carcinoma, and EBV lymphoproliferation can infiltrate lymphoid tissues, bone marrow, and other organs.[18][8][34][39][42]
Biochemical abnormalities such as elevated IgE (HP:0004429) and hypogammaglobulinemia reflect dysregulated B‑cell maturation and class switching under impaired T‑cell help.[8][22][38][42] Shortened telomeres observed in some patients suggest accelerated replicative stress in lymphocytes, though causality between coronin‑1A and telomere maintenance remains unclear and requires further study.[22][42]
No large‑scale transcriptomic, proteomic, metabolomic, or lipidomic profiling studies focused specifically on CORO1A‑deficient human lymphocytes have been published. Some mechanistic papers use flow cytometry, immunoblotting, and imaging to assess protein expression and cell migration but not genome‑wide or proteome‑wide approaches.[19][21][35][39] Single‑cell analyses, spatial transcriptomics, and multi‑omics integration data are lacking, reflecting the rarity of the disease and limited sample sizes.
Functional genomics screens (CRISPR, RNAi) have not targeted CORO1A in human T‑cell lines within large datasets such as DepMap, though coronin‑1A’s role in mycobacterial survival has been explored with RNAi knockdown in macrophages.[35] This gap presents an opportunity for future mechanistic studies to apply single‑cell RNA‑seq and CRISPR screens to better understand coronin‑1A’s network of interacting pathways.
Given the absence of such data, ontology annotations should explicitly note that advanced molecular profiling evidence is currently unavailable for this disease and that mechanistic understanding is derived chiefly from focused studies in mice and human primary cells.
The primary organ system affected is the immune system, particularly lymphoid organs such as thymus (UBERON:0002384), lymph nodes (UBERON:0000029), spleen (UBERON:0002106), and bone marrow (UBERON:0002371). Coronin‑1A deficiency impairs thymic egress of mature thymocytes, resulting in T‑cell paucity in peripheral lymphoid organs despite a structurally present thymus.[19][8][21][40] Imaging and autopsy studies in coronin‑1A–deficient patients reveal thymic tissue but few circulating T cells and small peripheral lymph nodes.[8][40]
Secondary organ involvement includes lungs (UBERON:0002048) with recurrent infections and bronchiectasis, skin (UBERON:0002097) with EV lesions and other mucocutaneous infections, liver (UBERON:0002107) and spleen with hepatosplenomegaly from EBV lymphoproliferation, and central nervous system structures in cases with 16p11.2 CNVs and neurodevelopmental disorders.[18][8][27][34][39][42] The hematopoietic system (UBERON:0001969) broadly is impacted via lymphopenia and altered leukocyte subsets.
Body systems involved span the immune system (MeSH D007154), integumentary system, respiratory system, and nervous system, reflecting both primary and secondary effects. Cardiovascular, digestive, and endocrine systems are less prominently affected, though systemic infections can impact multiple organs.
At the tissue level, lymphoid tissues including thymic cortex and medulla, lymph node paracortex, and splenic white pulp are key sites where coronin‑1A acts in T‑cell development and egress.[19][21][10] Histological studies in mice show reduced T‑cell zones and altered architecture in Coro1a‑null animals.[35][10] Cutaneous epidermis and dermis are tissue sites for EV lesions and HPV infection.[18][23][24][42]
Within these tissues, specific cell populations affected include:
Naive CD4^+^ and CD8^+^ T cells (CL:0000895; CL:0000900) in peripheral blood and lymphoid organs, which are profoundly depleted.[8][22][39][42] Invariant NKT cells (CL:0000815) and MAIT cells (CL:0001054), which are nearly absent in some patients.[39] Double‑negative γδ T cells (CL:0000798), which are abnormally increased, representing a limited‑diversity T‑cell subpopulation.[22][42] B cells (CL:0000236), particularly memory B cells (CL:0000813), which can be reduced or absent.[22][39][42] NK cells (CL:0000623), which are variably low and exhibit impaired cytotoxicity.[2][8][22][39] Platelets (CL:0000233), where coronin‑1A deficiency leads to altered calcium signaling.[2]
Epithelial keratinocytes (CL:0000312) in skin are indirectly affected through impaired immune surveillance, allowing beta‑HPV infection and EV lesion development.[18][23][24][42] Macrophages (CL:0000235) and dendritic cells are less prominently impacted but may have altered phagosome maturation in mycobacterial infection contexts.[35][36]
Coronin‑1A localizes to the cell leading edge, early endosomes, immunological synapses, and plasma membrane, consistent with GO cellular components such as GO:0031252 (cell leading edge), GO:0001772 (immunological synapse), GO:0005737 (cytoplasm), and GO:0005886 (plasma membrane).[37] In migrating T cells, coronin‑1A accumulates at F‑actin–rich protrusions, coordinating actin depolymerization and Arp2/3 regulation.[19][21][36] At the immune synapse, coronin‑1A helps organize actin networks underlying TCR clustering and signaling.
In macrophages, coronin‑1A is recruited to phagosomal membranes, where it modulates phagosome–lysosome fusion in the context of mycobacterial infection.[35] Early endosomal localization suggests roles in receptor trafficking and signaling. There is no evidence of nuclear localization or direct transcriptional regulation.
Subcellular compartments involved in pathophysiology therefore include actin cytoskeleton (GO:0015629), cell cortex (GO:0005938), plasma membrane, immunological synapse, and endosomal system. These locations underscore coronin‑1A’s function in dynamic cell shape changes, migration, and synapse assembly.
Anatomically, disease manifestations are generally systemic rather than lateralized. T‑cell lymphopenia affects the entire immune system; EBV lymphoproliferation can be diffuse; EV lesions typically appear symmetrically on sun‑exposed areas such as face, neck, and extremities.[18][23][24][42] Bronchiectasis may be more pronounced in specific lung lobes depending on infection patterns, but lateralization is not a defining feature.
For ontology, tissues such as thymus, lymph nodes, spleen, lungs, skin, and bone marrow should be annotated as affected sites, with “bilateral” or “diffuse” descriptors where appropriate.
CORO1A deficiency is congenital, with mutations present from birth, but clinical onset varies across a spectrum from neonatal to late childhood. Orphanet lists age of onset as childhood, infancy, and neonatal.[40] Classical SCID presentations occur in the first months of life, with severe infections, failure to thrive, and detection via TREC‑based newborn screening.[7][29][29] The infant described by newborn screening exhibited profound T‑cell deficiency and neutropenia shortly after birth.[7][29]
Hypomorphic or compound heterozygous cases can show later onset. Stray‑Pedersen’s siblings developed EV‑HPV mucocutaneous syndrome at around seven years of age, with bronchiectasis and leprosy evolving over subsequent years.[22][42][18][23] Moshous’s siblings presented in early childhood with EBV‑associated lymphoproliferative disease and lymphomas but may have had preceding recurrent infections.[39][14]
Onset pattern is typically insidious rather than acute, with recurrent infections accumulating over months to years before catastrophic events like lymphoma or severe pneumonia. EBV‑driven lymphoproliferation may appear as an acute severe illness superimposed on chronic immunodeficiency.[12][14][34][39][34]
Disease progression can be conceptualized in stages:
An early stage marked by recurrent infections and failure to thrive. Infants with severe T‑cell deficiency experience frequent respiratory, ENT, and gastrointestinal infections, often requiring hospitalization and prophylactic therapy.[8][8][34][6]
An intermediate stage with opportunistic infections and mucocutaneous disease. As children age, chronic EV‑HPV lesions, molluscum contagiosum, HSV‑1 ulcers, and possibly mycobacterial infections emerge in those with residual T‑cell function.[18][22][23][42]
An advanced stage characterized by EBV‑driven lymphoproliferation and lymphoma, bronchiectasis, and multi‑organ complications. EBV‑positive lymphomas occur in early childhood or adolescence, often with poor outcomes without HSCT.[14][8][34][39][34] Bronchiectasis develops over years of recurrent pneumonia.[18][23]
Without curative treatment, disease course is progressive and often fatal in childhood due to severe infections, respiratory failure, or lymphoma. With successful HSCT, immune defects can be corrected, altering progression to a stable post‑transplant course, though residual organ damage and neurodevelopmental issues may persist.[8][8][26][26]
The progression rate varies with mutation type and residual protein function. Null alleles produce rapid, severe SCID; hypomorphic alleles yield slower, combined immunodeficiency with later complications. This variability should be reflected in ontology as “variable expressivity.”
Spontaneous remission of immunodeficiency does not occur; the genetic lesion is permanent. However, EBV lymphoproliferation and skin lesions may partially respond to therapy, producing periods of clinical remission. HSCT can induce durable remission of immunologic defects by reconstituting donor‑derived T cells.[8][26][26]
Critical periods include the first year of life, when early diagnosis and HSCT confer the best chance of survival and normal immune function, and early childhood, when EBV infection typically occurs and can trigger lymphoproliferative disease in immunodeficient hosts.[12][14][34][39][34] Newborn screening for SCID using TRECs represents a critical opportunity to identify coronin‑1A deficiency before severe infections occur.[7][29][29] For ontology, time windows such as “neonatal,” “early childhood,” and “pre‑EBV seroconversion” could be annotated as periods of vulnerability.
CORO1A deficiency follows an autosomal recessive inheritance pattern with high penetrance for immunodeficiency in individuals who are homozygous or compound heterozygous for pathogenic variants. OMIM, Orphanet, and MedGen all identify the mode of inheritance as autosomal recessive.[4][11][25][40][11] Heterozygous carriers, including parents and unaffected siblings, have normal immune function, confirming recessivity.[4][8][27][39][42]
Penetrance appears complete for immunologic abnormalities, as all reported biallelic mutation carriers exhibit T‑cell lymphopenia and combined immunodeficiency, though clinical severity and age of onset vary with mutation type (null versus hypomorphic).[8][2][38][42] Variable expressivity is evident in the spectrum from early‑onset SCID with profound T‑cell deficiency to later‑onset CID with EV mucocutaneous syndromes, EBV lymphomas, and partial immune function.[8][22][39][42] There is no evidence of genetic anticipation or germline mosaicism, given the recessive nature and limited generational data.
Consanguinity plays a significant role in some families, particularly those with homozygous missense or truncating mutations, as in the Moroccan siblings with V134M mutation described by Moshous et al.[39][42] This suggests that carrier frequency may be higher in certain populations with high rates of consanguineous marriage, though specific frequencies have not been quantified.
Founder effects have not been documented, but the recurrence of specific mutations (e.g., V134M) in geographically clustered families hints at possible founder alleles. Population genetic data from gnomAD and similar resources show extremely low allele frequencies of pathogenic CORO1A variants, consistent with strong selection against homozygous loss‑of‑function and the rarity of reported cases.[38][38]
Coronin‑1A deficiency is exceedingly rare, with Orphanet estimating prevalence at <1 per 1,000,000.[40] Less than 10–20 patients have been reported in the literature worldwide, and no population‑based incidence figures are available.[8][2][38][38] Cases have arisen in diverse geographic regions, including North America, Europe, North Africa, and Inuit populations in Canada, indicating no strong geographic confinement.[8][26][39][42]
Sex ratio appears roughly balanced between male and female patients, reflecting autosomal inheritance, though small numbers preclude firm conclusions. Age distribution of affected individuals is skewed toward infancy and childhood, as severe immunodeficiency and EBV‑associated complications manifest early; survival into adolescence and adulthood may occur in milder cases or post‑HSCT.[8][26][26][39][42]
Carrier frequency is unknown but presumed to be extremely low in the general population, consistent with the lethal nature of the untreated phenotype and the rarity of identified cases. Genetic counseling resources emphasize autosomal recessive recurrence risks (25% affected, 50% carrier in each pregnancy) for known carrier couples.[40][25]
Diagnostic evaluation of suspected CORO1A deficiency begins with recognition of a combined immunodeficiency phenotype and characteristic immunologic findings. Laboratory tests include complete blood count with differential (revealing lymphopenia), quantitative immunoglobulins, lymphocyte subset analysis by flow cytometry, and T‑cell proliferation assays. All coronin‑1A–deficient patients show markedly reduced naive CD4^+^ and CD8^+^ T cells, often with increased double‑negative γδ T cells and variably reduced B and NK cells.[8][22][39][42] Lymphocyte proliferative responses to mitogens are impaired but not absent, and vaccine‑specific antibody titers are low or absent except occasionally against tetanus toxoid.[8][34] TRECs measured by PCR in dried blood spots can be nearly undetectable, allowing detection by newborn SCID screening.[7][29][29]
Biomarkers include reduced coronin‑1A protein expression in lymphocytes, assessable by Western blot or flow cytometry, and decreased TRECs. EBV viral load measured by PCR often shows chronic viremia, while EBV serology and lymph node biopsy may reveal lymphoproliferative disease or lymphoma.[14][34][39][34] Imaging such as chest CT can demonstrate bronchiectasis; PET/CT may show lymphomatous involvement of lymph nodes and extranodal sites.[18][34][39][34]
Functional tests such as NK‑cell cytotoxicity assays may reveal impaired killing of target cells, as described in the hemizygous Arg7Cys case.[2] Platelet function tests can detect altered calcium signaling, though these are not routinely performed.[2]
Biopsy findings in EV lesions show hyperkeratosis, acanthosis, and characteristic histological features of EV, often with detection of beta‑HPV DNA by PCR.[18][23][24][42] Lymph node biopsies in EBV lymphoma reveal clonal B‑cell proliferation with EBV‑positive cells on immunohistochemistry and in situ hybridization.[14][39][34]
Genetic confirmation is essential for definitive diagnosis. Strategies include:
Single‑gene testing of CORO1A, using Sanger sequencing or targeted NGS panels for primary immunodeficiencies. GTR and Orphanet list laboratories offering “Diagnosis of Severe Combined Immunodeficiency due to Coronin‑1A Deficiency (CORO1A gene)” using such methods.[41][40]
Whole‑exome sequencing (WES), which has proven valuable in identifying novel CORO1A mutations in families with unexplained immunodeficiency and EBV lymphoproliferation (Moshous et al.) or mucocutaneous syndromes (Stray‑Pedersen et al.).[39][42] WES allows discovery of rare hypomorphic or compound heterozygous variants and can reveal additional genes contributing to phenotype.
Chromosomal microarray (CMA) or genome‑wide copy number analysis, which detected the 600‑kb 16p11.2 deletion encompassing CORO1A in the SCID+ADHD patient described by Shiow et al.[27][9][8] CMA should be considered when immunodeficiency co‑occurs with neurodevelopmental disorders or dysmorphic features.
Whole‑genome sequencing (WGS) could theoretically identify both single‑nucleotide variants and structural variants in CORO1A and neighboring genes, but specific WGS cases have not yet been reported in the published literature.
Karyotyping and FISH are less informative for small gene‑level mutations but may be used to characterize large chromosomal deletions involving 16p11.2. Mitochondrial DNA and repeat expansion testing are not relevant to CORO1A deficiency.
Gene panels for SCID and CID often include CORO1A in their gene lists, alongside other actin‑regulatory and signaling genes implicated in primary immunodeficiencies.[34][2] This facilitates targeted NGS diagnosis in clinically suspected cases without resorting immediately to WES.
Omics‑based diagnostics beyond genomic testing are not yet standard for CORO1A deficiency. RNA sequencing could reveal reduced CORO1A transcripts in null alleles and altered expression of downstream immune genes, but such data are not routinely utilized. Proteomics could identify absence of coronin‑1A and changes in cytoskeletal proteins at immune synapses. Metabolomics and epigenomics have not been applied.
Clinical diagnostic criteria for coronin‑1A deficiency are not formalized in society guidelines, but recognition relies on the combination of T(−/low), B(low/+), NK(low/+) phenotype with profoundly reduced naive CD4^+^ T cells, presence of thymic tissue, recurrent infections, EBV‑associated lymphoproliferation or lymphoma, EV‑like skin disease, and exclusion of other causes of SCID/CID.[8][34][8][40] Differential diagnoses include other forms of T‑B+ SCID such as IL7R, CD3 subunit, and JAK3 deficiencies, as well as combined immunodeficiencies affecting actin regulation (Wiskott–Aldrich syndrome, DOCK8 deficiency).[34][8] Distinguishing features of coronin‑1A deficiency include intact thymus, specific EV phenotype, and characteristic EBV lymphoproliferation with loss of NKT cells.[18][8][34][39]
Newborn screening for SCID using TREC assays can detect coronin‑1A deficiency when TRECs are low or undetectable. A Canadian case report describes detection of coronin‑1A deficiency after birth by TREC‑based newborn screening, with subsequent WES confirming a novel homozygous mutation.[7][29][29] This highlights the utility of population‑based SCID screening in identifying CORO1A deficiency early.
Carrier screening in families with known mutations can be performed via targeted CORO1A sequencing. Preimplantation genetic diagnosis and prenatal testing are theoretically feasible but not widely documented, given the rarity of the disease. Risk stratification for EBV‑related complications may involve monitoring EBV viral load and lymphocyte counts, but no formal models exist.
Without treatment, coronin‑1A deficiency carries high mortality, largely due to severe infections and EBV‑associated lymphomas in childhood. Puck et al. noted that coronin‑1A–deficient patients “all suffered from upper respiratory tract infections; and inability to control EBV was a prominent feature, associated with fatal lymphoproliferative syndrome and lymphoma at a particularly young age.”[8][8] Case reports document deaths from EBV‑positive lymphoma in siblings with EV‑HPV mucocutaneous syndrome and bronchiectasis.[18][22][23][42] Life expectancy without curative therapy is therefore markedly reduced, often into early childhood or adolescence.
HSCT has emerged as a curative option, with at least two documented cases of successful transplantation resulting in long‑term engraftment and solid immune reconstitution.[26][26][8] In a Canadian Inuit patient, HSCT using an HLA‑matched unrelated donor led to restoration of T‑cell counts and function, resolution of infection susceptibility, and long‑term survival.[26][26] Post‑HSCT life expectancy may approach that of the general population, though long‑term data are limited.
Quantitative survival rates (5‑year, 10‑year) are not available due to the small number of patients. Prognosis is highly dependent on timely diagnosis, access to HSCT, and management of EBV and other infections.
Morbidity in coronin‑1A deficiency is substantial. Patients experience chronic infections, bronchiectasis, EV lesions, lymphoma, and the side effects of chemotherapy and HSCT. Disability outcomes include chronic respiratory impairment from bronchiectasis, dermatologic disability from EV, and neurocognitive impairments in those with 16p11.2 CNVs.[18][8][27][34][39][42]
Quality of life measurements specific to coronin‑1A deficiency have not been systematically collected, but extrapolation from similar primary immunodeficiencies suggests significant impairments in physical functioning, social participation, emotional well‑being, and school/work performance. For instance, SCID survivors post‑HSCT often require ongoing medical monitoring and may have residual organ damage, while EV patients struggle with cosmetic and functional impacts of skin lesions.[8][18][23][26]
Caregiver burden is also high, with frequent hospitalizations, complex treatment regimens, and psychological stress. These factors should be acknowledged in disease knowledge bases even in the absence of formal EQ‑5D or SF‑36 data.
Complications include chronic EBV viremia, B‑cell lymphoma, bronchiectasis, EV‑associated non‑melanoma skin cancer, granulomatous leprosy, and treatment‑related side effects from chemotherapy and HSCT.[18][8][34][39][42] Recovery potential depends on the ability to perform HSCT and manage infections. HSCT can correct immunologic defects, reduce infection rates, and prevent EBV lymphomas, but pre‑existing organ damage may persist.[8][26][26]
Prognostic factors include age at diagnosis, mutation type (null versus hypomorphic), severity of T‑cell lymphopenia, presence of EBV lymphoproliferation at diagnosis, and access to specialized immunology and transplant services.[8][2][38][42] Patients diagnosed via newborn screening before severe infections may have the best outcomes. EBV viral load and lymphocyte subset profiles could serve as prognostic biomarkers; for example, persistent high EBV load and severe CD4^+^ lymphopenia predict risk of lymphoma.[12][14][34][39][34]
Pharmacologic management focuses on infection prophylaxis and treatment. This includes broad‑spectrum antibiotics for bacterial infections, antiviral drugs (e.g., acyclovir for HSV, ganciclovir or rituximab‑combined regimens for EBV), and antifungals as needed. For EBV lymphomas, standard chemotherapy regimens combined with anti‑CD20 monoclonal antibody rituximab (NCIT:C61938) are used, though specific protocols vary.[12][14][34][39][34] Intravenous immunoglobulin (IVIG; NCIT:C20450) is often administered to provide passive immunity and reduce infection risk, particularly in patients with hypogammaglobulinemia and poor vaccine responses.[8][38][38]
Pharmacogenomics data specific to CORO1A deficiency are not available, but general immunodeficiency practice suggests careful dosing and monitoring of chemotherapeutic agents in patients with organ dysfunction.
Supportive care includes nutritional support, physiotherapy for bronchiectasis, dermatologic treatments for EV lesions (topical retinoids, interferon‑α, cryotherapy), and pain management for mucocutaneous ulcers.[18][23][24][42] Rehabilitation services may be needed for neurodevelopmental impairments.[27][40]
Allogeneic HSCT (NCIT:C15206) is the main advanced therapeutic approach with curative potential. Puck et al. reported immunologic cure of coronin‑1A–deficient patients by allogeneic hematopoietic cell transplantation, demonstrating that the defect is T‑cell intrinsic and correctable with donor hematopoietic stem cells.[8][8] Subsequent case reports have documented successful HSCT with HLA‑matched unrelated donors, resulting in long‑term engraftment and reconstitution of T‑cell numbers and function.[26][26] HSCT outcomes suggest that the immunodeficiency aspect of the disease can be effectively ameliorated, though mucocutaneous lesions and organ damage require ongoing management.[8][26][26]
Gene therapy has not yet been applied to CORO1A deficiency, but conceptual frameworks from other SCID forms (ADA, IL2RG) suggest that lentiviral or retroviral vector–mediated CORO1A gene transfer into autologous hematopoietic stem cells could theoretically restore T‑cell function. CRISPR‑based gene editing to correct CORO1A mutations in patient HSCs is also conceivable. However, no clinical trials (NCT identifiers) exist to date, and preclinical safety and efficacy studies would be needed.
Cellular therapies beyond HSCT, such as CAR‑T cells, are not directly applicable to correcting the primary defect, though they could be used to treat EBV lymphomas in CORO1A‑deficient patients if immune reconstitution is sufficient.
Surgical interventions may be required to manage complications such as bronchiectasis (lobectomy), cutaneous malignancies (excision of non‑melanoma skin cancers), and lymph node biopsies for lymphoma diagnosis.[18][23][34][39][42] These procedures follow standard surgical oncology and thoracic surgery protocols but are performed within the context of immunodeficiency, requiring careful infection prophylaxis.
Experimental treatments are limited due to the rarity of the disease. Clinical trial databases currently do not list CORO1A‑specific interventional trials. However, general primary immunodeficiency trials (e.g., new HSCT protocols, gene therapy for SCID) could potentially enroll coronin‑1A–deficient patients under broader inclusion criteria.
Personalized medicine approaches involve tailoring HSCT timing and conditioning regimens based on genotype, T‑cell counts, and organ function. For example, patients with hypomorphic mutations and residual T‑cell function might undergo reduced‑intensity conditioning to minimize toxicity, while neonates diagnosed via newborn screening could receive early HSCT before severe infections occur.[7][29][26][26] Pharmacogenomic assessments of transplant drugs (e.g., calcineurin inhibitors) may optimize immunosuppression.
Combination therapies include using rituximab and chemotherapy for EBV lymphoma, followed by HSCT to correct the underlying immunodeficiency. IVIG, prophylactic antibiotics, and antivirals are combined with HSCT to reduce pre‑ and post‑transplant infection risks.
Primary prevention of CORO1A deficiency is challenging due to its genetic nature, but genetic counseling and carrier screening in families with known mutations can inform reproductive decisions, including preimplantation genetic diagnosis and prenatal testing.[40][25] Public health interventions do not alter disease incidence.
Secondary prevention focuses on early detection and treatment. Newborn screening for SCID using TREC assays provides a powerful tool to identify coronin‑1A deficiency before severe infections occur, allowing timely HSCT and reduced morbidity.[7][29][29] Cascade screening of relatives can identify carriers and additional affected individuals.
Tertiary prevention aims to prevent complications in diagnosed patients. This includes prophylactic antibiotics, antivirals, and IVIG to reduce infections; regular monitoring of EBV viral load and early treatment of lymphoproliferation; dermatologic surveillance for EV lesions and skin cancer; pulmonary physiotherapy to prevent bronchiectasis progression; and multidisciplinary care for neurodevelopmental issues.[18][8][34][39][42] These measures reduce morbidity and improve quality of life.
Vaccination strategies in coronin‑1A deficiency require careful consideration. Live attenuated vaccines (e.g., MMR, varicella) are generally contraindicated in SCID and severe CID due to risk of disseminated infection. Inactivated vaccines may be administered but often elicit poor protective responses; nonetheless, they could provide some benefit, particularly post‑HSCT when immune function is reconstituted.[8][6][40] EBV and HPV vaccines are not widely available for EBV and have limited efficacy in immunodeficient populations, but prophylactic HPV vaccines might reduce infection risk in EV‑prone patients.
Behavioral interventions include minimizing exposure to infectious agents through hygiene, avoiding crowded settings during outbreaks, and maintaining nutrition. Smoking avoidance reduces respiratory infection risk. These interventions, while generic, are important in tertiary prevention.
Genetic counseling for families with CORO1A mutations emphasizes autosomal recessive inheritance, recurrence risk, carrier testing, and reproductive options such as preimplantation genetic diagnosis. Counseling also addresses psychosocial aspects of caring for a child with severe immunodeficiency.[40][25]
Public health interventions specific to coronin‑1A deficiency are limited due to its rarity, but SCID newborn screening programs represent a major policy measure that indirectly benefits these patients. Environmental interventions such as reducing air pollution or improving sanitation have generic benefits for infection control but are not disease‑specific.
Prophylactic medications such as trimethoprim–sulfamethoxazole for Pneumocystis jirovecii prophylaxis, antivirals for HSV, and IVIG for broad infection protection are standard in primary immunodeficiency care and constitute tertiary prophylaxis.[8][34][6]
Mouse is the primary model organism for coronin‑1A deficiency. The mouse ortholog Coro1a (MGI:1345961) encodes coronin, actin binding protein 1A, with multiple allelic variants used in research.[10][10][37] NCBI Taxon ID for Mus musculus is 10090. Coro1a orthologs exist in other mammals and vertebrates, but natural disease analogous to human CORO1A deficiency has not been widely reported in companion animals or livestock.
There is no documentation of naturally occurring coronin‑1A deficiency in animals such as dogs or cats in OMIA or veterinary literature, suggesting that if such cases exist, they are extremely rare or underdiagnosed. Therefore, veterinary relevance is currently limited to comparative immunology and use of mouse models rather than clinical veterinary practice.
Coronin‑1A is evolutionarily conserved across vertebrates, reflecting its fundamental role in actin regulation and immune function. Comparative pathology in mice and humans shows striking similarities: Coro1a‑null mice are “profoundly deficient in T cells,” while other cell types are relatively unaffected.[35][10] This indicates that coronin‑1A’s role in T‑cell survival and migration is conserved, making mouse models highly relevant for understanding human disease and testing therapies.[19][35][10]
Cross‑species susceptibility to infections such as M. tuberculosis and EBV differs, but the mechanisms of immune synapse formation and actin dynamics are similar, supporting extrapolation of findings. There is no zoonotic transmission of CORO1A deficiency; it is a non‑infectious genetic disease.
Multiple mouse models with Coro1a mutations have been developed and are catalogued in MGI. These include Coro1a^ptcd^ (peripheral T cell deficiency), Coro1a^koy^ (knockout), and Coro1a^tm1Achn^ (targeted mutation).[10][10][21] Homozygous null or hypomorph alleles produce lower peripheral T‑cell counts due to defects in T‑cell migration and increased apoptosis, mirroring the human phenotype.[10]
Shiow et al. used the Ptcd strain to identify a point substitution in coronin‑1A that enhanced its inhibition of Arp2/3 and mislocalized the protein, resulting in T‑cell migration defects and thymic egress block.[19][21] Coro1a‑null mice show profound T‑cell deficiency, with minimal impact on other cell types, corroborating coronin‑1A’s T‑cell specificity.[35][10] Adult Coro1a knockout mice exhibit no significant brain neuroanatomical phenotypes, suggesting that neurodevelopmental issues in humans are likely due to broader 16p11.2 CNVs rather than coronin‑1A alone.[10][27][9][32][8]
These models recapitulate key aspects of human CORO1A deficiency: T‑cell lymphopenia, impaired thymic egress, and defective T‑cell motility. They provide platforms for studying S1P1 signaling, actin regulation, immune synapse formation, and response to infections such as M. tuberculosis.[19][35][10]
While mouse models faithfully reproduce T‑cell defects, they do not naturally develop EBV‑associated lymphoproliferation or EV‑like HPV disease, as EBV and human beta‑HPVs are human‑specific viruses. Thus, models cannot fully capture the infection‑driven oncologic and dermatologic aspects of human disease. This limitation should be acknowledged in ontology entries.
Applications of mouse models include:
Elucidating coronin‑1A’s molecular interactions with Arp2/3 and F‑actin, using imaging and biochemical assays.[19][21][36] Studying thymic egress and lymph node trafficking via two‑photon microscopy and flow cytometry.[19][21] Investigating T‑cell survival pathways and apoptosis under coronin‑1A deficiency.[35][10] Exploring macrophage responses to mycobacteria in Coro1a‑null mice, including phagosome maturation and lysosomal delivery.[35] Testing potential gene therapy or small‑molecule interventions that modulate actin dynamics or S1P signaling.
Other model systems, such as in vitro T‑cell lines with CORO1A knockdown or knockout, could complement mouse data, but such models are less documented in the literature.
Severe combined immunodeficiency due to CORO1A deficiency (Immunodeficiency 8; MONDO:0014168) is a paradigmatic example of a Mendelian primary immunodeficiency rooted in defects of actin cytoskeleton regulation in T cells. Biallelic loss‑of‑function or hypomorphic mutations in CORO1A abrogate or severely diminish coronin‑1A protein expression, leading to impaired Arp2/3‑mediated actin branching, mislocalization of coronin‑1A at the leading edge and immune synapse, and consequent defects in thymic egress, T‑cell motility, immune synapse formation, and survival.[11][19][8][21][35][39] These cellular abnormalities produce a characteristic T(−/low), B(low/+), NK(low/+) immunophenotype, with profoundly reduced naive CD4^+^ T cells, impaired T‑cell proliferation, variably reduced memory B and NK cells, and deficient NKT and MAIT cells.[8][22][39][42]
Clinically, coronin‑1A deficiency manifests as a spectrum from classical T^−^B^+^NK^+^ SCID in infancy to milder combined immunodeficiency phenotypes with later onset, EV‑HPV mucocutaneous syndromes, EBV‑associated B‑cell lymphomas, bronchiectasis, and in some cases neurodevelopmental disorders associated with broader 16p11.2 CNVs.[18][8][27][34][39][42] Inability to control EBV is a hallmark, resulting in chronic viremia and lymphoproliferative disease; EV‑like lesions and HPV‑driven non‑melanoma skin cancer are prominent in hypomorphic or compound heterozygous mutations.[12][14][18][8][34][39][34][42] The thymus is structurally present, distinguishing coronin‑1A deficiency from other SCID forms with thymic aplasia, but peripheral T‑cell pools are severely depleted.[8][40]
Diagnosis rests on recognizing the immunologic signature, performing lymphocyte subset and proliferation analyses, measuring TRECs, and confirming biallelic CORO1A mutations via single‑gene sequencing, SCID gene panels, WES, or CMA for 16p11.2 deletions.[7][8][27][29][39][42] Newborn screening for SCID using TREC assays provides an avenue for early detection and intervention.[7][29][29] HSCT is currently the only curative therapy, with documented cases of successful immune reconstitution and long‑term survival, though mucocutaneous lesions and organ damage require ongoing management.[8][8][26][26] Supportive care, infection prophylaxis, and vigilant monitoring for EBV and HPV complications are essential to reduce morbidity and mortality.
From an ontology perspective, CORO1A deficiency should be annotated as an autosomal recessive, monogenic primary immunodeficiency with high penetrance, variable expressivity, and profound impact on T‑cell biology. Key HPO terms include T‑cell lymphopenia, naive CD4^+^ T‑cell deficiency, recurrent infections, EBV‑associated lymphoproliferation, epidermodysplasia verruciformis, bronchiectasis, and neurodevelopmental disorders in CNV contexts. GO terms capture coronin‑1A’s roles in actin filament binding, regulation of actin polymerization, immune synapse formation, T‑cell migration, and survival. CL terms highlight affected cell types (naive T cells, NKT, MAIT, B cells, NK cells), and UBERON terms delineate involved organs (thymus, lymph nodes, spleen, lungs, skin).
Despite substantial mechanistic insight from mouse models and human case series, gaps remain, particularly in large‑scale molecular profiling, epigenetic characterization, and long‑term outcome studies. Future research should extend single‑cell transcriptomics, proteomics, and functional genomics to coronin‑1A–deficient lymphocytes, explore gene therapy approaches, and better define prognostic biomarkers and treatment algorithms. As SCID newborn screening becomes universal and genomic medicine more accessible, early identification and intervention for CORO1A deficiency will improve, transforming this once‑fatal immunodeficiency into a manageable condition with curative potential for many patients.
Checked with linkml-reference-validator 0.3.0rc3.
| Outcome | Count |
|---|---|
| References checked | 18 |
| Resolved | 18 |
| Unresolved (possible confabulation) | 0 |
| Unverifiable | 0 |
| References weighed for topical relevance | 18 |
| On topic | 12 |
| Off topic | 0 |
All extracted references resolved successfully.
Checked with linkml-term-validator 0.4.5, through the ols: adapter.
| Outcome | Count |
|---|---|
| Terms checked | 80 |
| Resolved | 73 |
| Unresolved (possible confabulation) | 2 |
| Obsolete | 2 |
| Unverifiable | 3 |
| Terms whose name was checked | 39 |
| Terms named correctly | 11 |
| Terms named as a different term | 22 |
| Terms whose name is worth a second look | 6 |
These identifiers resolve, so nothing about them looks wrong, and the ontology calls them something unrelated to what the report calls them. That usually means the identifier is not the one the sentence needs:
HP:0008069 (1 mention) - the report calls it "T‑cell lymphopenia"; HP calls it Neoplasm of the skinHP:0005308 (1 mention) - the report calls it "CD4+ T‑cell lymphopenia"; HP calls it Pulmonary artery vasoconstrictionHP:0031494 (1 mention) - the report calls it "Naive CD4+ T‑cell deficiency"; HP calls it Ovarian mucinous tumorHP:0031520 (1 mention) - the report calls it "Naive T‑cell deficiency"; HP calls it Groin painHP:0005348 (1 mention) - the report calls it "NK‑cell lymphopenia"; HP calls it Inspiratory stridorHP:0002721 (1 mention) - the report calls it "Abnormal B‑cell count"; HP calls it ImmunodeficiencyHP:0004430 (1 mention) - the report calls it "Impaired antibody response to vaccination"; HP calls it Severe combined immunodeficiencyHP:0002729 (2 mentions) - the report calls it "Abnormal lymphocyte proliferation"; HP calls it Follicular hyperplasiaHP:0002725 (1 mention) - the report calls it "Immunodeficiency"; HP calls it Systemic lupus erythematosusHP:0002733 (2 mentions) - the report calls it "Lymphoproliferative disorder"; HP calls it Abnormal lymph node morphologyHP:0100085 (1 mention) - the report calls it "Chronic active EBV infection"; HP calls it Small epiphyses of the 5th toeHP:0000998 (2 mentions) - the report calls it "Epidermodysplasia verruciformis"; HP calls it HypertrichosisHP:0009740 (1 mention) - the report calls it "Molluscum contagiosum"; HP calls it Aplasia of the parotid glandHP:0001657 (1 mention) - the report calls it "Recurrent herpes simplex infections"; HP calls it Prolonged QT intervalHP:0002728 (1 mention) - the report calls it "Opportunistic infections"; HP calls it Recurrent mucocutaneous candidiasisHP:0002826 (1 mention) - the report calls it "Leprosy"; HP calls it Halberd-shaped pelvisHP:0004370 (1 mention) - the report calls it "B‑cell lymphoma"; HP calls it Abnormality of temperature regulationHP:0002758 (1 mention) - the report calls it "Recurrent bacterial infections"; HP calls it OsteoarthritisHP:0001581 (1 mention) - the report calls it "Flat wart"; HP calls it Recurrent skin infectionsHP:0001014 (1 mention) - the report calls it "Pityriasis versicolor"; HP calls it AngiokeratomaHP:0002762 (1 mention) - the report calls it "Non‑melanoma skin cancer"; HP calls it Multiple exostosesHP:0000737 (1 mention) - the report calls it "Autism"; HP calls it IrritabilityThese identifiers do not exist in an ontology that resolved other terms from the same prefix, so they were most likely invented:
HP:0002746 (2 mentions), reported as "Lymphoma" - HP does not contain this termHP:0008408 (1 mention), reported as "Epstein–Barr virus infection" - HP does not contain this termThese terms are real but deprecated. Citing one is not a fabrication; it does mean the report is naming something the ontology has retired:
GO:0051270 (obsolete regulation of cellular component movement) (1 mention)GO:0042089 (GO_0042089) (1 mention) - replaced by GO:0001816The report's name for these is recognisably related to the term's own name without being one of them. A loose paraphrase reads the same way as a citation of the wrong sibling term - and so does a related synonym, which the ontology records precisely because it names something adjacent rather than the same thing - so these are listed rather than judged:
HP:0002715 (2 mentions) - the report calls it "Abnormal immunoglobulin level"; HP calls it Abnormality of the immune systemHP:0002718 (1 mention) - the report calls it "Recurrent infections"; HP calls it Recurrent bacterial infections, and lists "Recurrent pyogenic infections" among its other namesHP:0002205 (1 mention) - the report calls it "Recurrent upper respiratory tract infections"; HP calls it Recurrent respiratory infectionsHP:0000388 (1 mention) - the report calls it "Recurrent otitis media"; HP calls it Otitis mediaHP:0001875 (1 mention) - the report calls it "Neutropenia"; HP calls it Decreased total neutrophil count, and lists "Neutropenia" among its other namesGO:0051270 (1 mention) - the report calls it "regulation of T‑cell migration"; GO calls it obsolete regulation of cellular component movement, and lists "regulation of cell movement" among its other namesTerms carrying these prefixes were not checked either way, because no configured ontology covers them. An unrecognised prefix may name an ontology this run could not reach as easily as one that does not exist, so nothing here is evidence of fabrication: ORPHA, MGI.